Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic
Owing to the diversity and ease of preparation of nanomaterials, the rational nanocarriers with a rational design have become increasingly popular in medical researches. Although nanoparticle-based drug delivery exhibits great potential, there are some challenges facing like rapid plasma clearance,...
Saved in:
| Published in | Journal of controlled release Vol. 294; pp. 102 - 113 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
28.01.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Owing to the diversity and ease of preparation of nanomaterials, the rational nanocarriers with a rational design have become increasingly popular in medical researches. Although nanoparticle-based drug delivery exhibits great potential, there are some challenges facing like rapid plasma clearance, triggering or aggravation of immune response, etc. Herein, cell-based targeted drug delivery systems have drawn more and more attention owing to low immunogenicity and intrinsic mutation rate, and innate ability to allow targeted delivery. Mesenchymal stem cells (MSCs) have been used in gene and drug delivery. The use of MSCs is a promising approach for the development of gene transfer systems and drug loading strategies because of their intrinsic properties, including homing ability and tumor tropism. By combining the inherent cell properties and merits of synthetic nanoparticles (NPs), cell membrane coated NPs emerge as the time requires. Overall, we provide a comprehensive overview of the utility of MSCs in drug and gene delivery as well as MSC membrane coated nanoparticles for therapy and drug delivery, aiming to figure out the significant room for development and highlight the potential future directions.
[Display omitted] |
|---|---|
| AbstractList | Owing to the diversity and ease of preparation of nanomaterials, the rational nanocarriers with a rational design have become increasingly popular in medical researches. Although nanoparticle-based drug delivery exhibits great potential, there are some challenges facing like rapid plasma clearance, triggering or aggravation of immune response, etc. Herein, cell-based targeted drug delivery systems have drawn more and more attention owing to low immunogenicity and intrinsic mutation rate, and innate ability to allow targeted delivery. Mesenchymal stem cells (MSCs) have been used in gene and drug delivery. The use of MSCs is a promising approach for the development of gene transfer systems and drug loading strategies because of their intrinsic properties, including homing ability and tumor tropism. By combining the inherent cell properties and merits of synthetic nanoparticles (NPs), cell membrane coated NPs emerge as the time requires. Overall, we provide a comprehensive overview of the utility of MSCs in drug and gene delivery as well as MSC membrane coated nanoparticles for therapy and drug delivery, aiming to figure out the significant room for development and highlight the potential future directions. Owing to the diversity and ease of preparation of nanomaterials, the rational nanocarriers with a rational design have become increasingly popular in medical researches. Although nanoparticle-based drug delivery exhibits great potential, there are some challenges facing like rapid plasma clearance, triggering or aggravation of immune response, etc. Herein, cell-based targeted drug delivery systems have drawn more and more attention owing to low immunogenicity and intrinsic mutation rate, and innate ability to allow targeted delivery. Mesenchymal stem cells (MSCs) have been used in gene and drug delivery. The use of MSCs is a promising approach for the development of gene transfer systems and drug loading strategies because of their intrinsic properties, including homing ability and tumor tropism. By combining the inherent cell properties and merits of synthetic nanoparticles (NPs), cell membrane coated NPs emerge as the time requires. Overall, we provide a comprehensive overview of the utility of MSCs in drug and gene delivery as well as MSC membrane coated nanoparticles for therapy and drug delivery, aiming to figure out the significant room for development and highlight the potential future directions. [Display omitted] Owing to the diversity and ease of preparation of nanomaterials, the rational nanocarriers with a rational design have become increasingly popular in medical researches. Although nanoparticle-based drug delivery exhibits great potential, there are some challenges facing like rapid plasma clearance, triggering or aggravation of immune response, etc. Herein, cell-based targeted drug delivery systems have drawn more and more attention owing to low immunogenicity and intrinsic mutation rate, and innate ability to allow targeted delivery. Mesenchymal stem cells (MSCs) have been used in gene and drug delivery. The use of MSCs is a promising approach for the development of gene transfer systems and drug loading strategies because of their intrinsic properties, including homing ability and tumor tropism. By combining the inherent cell properties and merits of synthetic nanoparticles (NPs), cell membrane coated NPs emerge as the time requires. Overall, we provide a comprehensive overview of the utility of MSCs in drug and gene delivery as well as MSC membrane coated nanoparticles for therapy and drug delivery, aiming to figure out the significant room for development and highlight the potential future directions.Owing to the diversity and ease of preparation of nanomaterials, the rational nanocarriers with a rational design have become increasingly popular in medical researches. Although nanoparticle-based drug delivery exhibits great potential, there are some challenges facing like rapid plasma clearance, triggering or aggravation of immune response, etc. Herein, cell-based targeted drug delivery systems have drawn more and more attention owing to low immunogenicity and intrinsic mutation rate, and innate ability to allow targeted delivery. Mesenchymal stem cells (MSCs) have been used in gene and drug delivery. The use of MSCs is a promising approach for the development of gene transfer systems and drug loading strategies because of their intrinsic properties, including homing ability and tumor tropism. By combining the inherent cell properties and merits of synthetic nanoparticles (NPs), cell membrane coated NPs emerge as the time requires. Overall, we provide a comprehensive overview of the utility of MSCs in drug and gene delivery as well as MSC membrane coated nanoparticles for therapy and drug delivery, aiming to figure out the significant room for development and highlight the potential future directions. |
| Author | Tabata, Yasuhiko Gao, Jian-Qing Wu, Hong-Hui Zhou, Yi |
| Author_xml | – sequence: 1 givenname: Hong-Hui surname: Wu fullname: Wu, Hong-Hui organization: Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, PR China – sequence: 2 givenname: Yi surname: Zhou fullname: Zhou, Yi organization: Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, PR China – sequence: 3 givenname: Yasuhiko surname: Tabata fullname: Tabata, Yasuhiko organization: Laboratory of Biomaterials, Department of Regeneration Science and Engineering, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan – sequence: 4 givenname: Jian-Qing orcidid: 0000-0003-1052-7060 surname: Gao fullname: Gao, Jian-Qing email: gaojianqing@zju.edu.cn organization: Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, PR China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30553849$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUlPwzAUhC0EgrL8BFCOXBK8xEkMB4QqNqmIC5wtLy_gKonBdpH670lp4cClpzm8b0ZPM4dod_ADIHRKcEEwqS7mxdz4IUBXUEyagtACE7GDJqSpWV4KwXfRZOSanFVcHKDDGOcYY87Keh8dMMw5a0oxQbMniDCY92Wvuiwm6DMDXZdrFcFmNizeMgud-4KwHK9BJXhbXmZt8GsuZsln2vne9ZCcOUZ7reoinGz0CL3e3b5MH_LZ8_3j9GaWG45Jyhlhta5awcpGAzdU2LbhVaWBqprbkoDWhmGAioOlLW9A4VbjUUuNbVUzdoTO17kfwX8uICbZu7j6Rw3gF1FSSnHDWU3EdpTwuuJ1KfiInm3Qhe7Byo_gehWW8resEeBrwAQfY4D2DyFYrkaRc7kZRa5GkYRK_PPD1T-fcUkl54exUddtdV-v3TA2-uUgyGjcOBlYF8Akab3bkvANIQ-rkw |
| CitedBy_id | crossref_primary_10_3389_fonc_2024_1389775 crossref_primary_10_1002_cjoc_202100946 crossref_primary_10_1002_adfm_202102440 crossref_primary_10_1016_j_mtbio_2023_100789 crossref_primary_10_1002_advs_202401095 crossref_primary_10_2147_IJN_S433737 crossref_primary_10_1016_j_ijpharm_2022_121757 crossref_primary_10_3390_bioengineering7030111 crossref_primary_10_1016_j_actbio_2023_11_029 crossref_primary_10_1186_s13287_022_02794_3 crossref_primary_10_1016_j_ijpharm_2024_124580 crossref_primary_10_1126_sciadv_abn1805 crossref_primary_10_4103_jmau_jmau_90_24 crossref_primary_10_1002_wnan_1792 crossref_primary_10_1039_D4NR00284A crossref_primary_10_3390_ijms24119293 crossref_primary_10_1002_adhm_202400704 crossref_primary_10_1016_j_ccr_2024_216101 crossref_primary_10_1039_D2NR07071E crossref_primary_10_1016_j_nantod_2023_101798 crossref_primary_10_1016_j_colsurfb_2021_112163 crossref_primary_10_1002_adma_202402445 crossref_primary_10_1002_adma_202304333 crossref_primary_10_1016_j_bioactmat_2024_05_015 crossref_primary_10_1186_s12951_022_01593_5 crossref_primary_10_1016_j_mtbio_2022_100377 crossref_primary_10_1039_D0TB00472C crossref_primary_10_1155_2019_8035076 crossref_primary_10_1016_j_apsb_2022_04_001 crossref_primary_10_1016_j_intimp_2021_107437 crossref_primary_10_2147_IJN_S382519 crossref_primary_10_1021_acsami_2c12004 crossref_primary_10_2147_IJN_S254774 crossref_primary_10_1016_j_cej_2023_144145 crossref_primary_10_1080_13813455_2024_2447532 crossref_primary_10_1016_j_ccr_2024_215712 crossref_primary_10_1007_s12015_021_10192_0 crossref_primary_10_1016_j_ijpharm_2021_120477 crossref_primary_10_1002_smtd_202401425 crossref_primary_10_1002_VIW_20240043 crossref_primary_10_1016_j_biomaterials_2021_121224 crossref_primary_10_34133_research_0429 crossref_primary_10_3390_ijms251910394 crossref_primary_10_1016_j_apsb_2022_02_023 crossref_primary_10_1016_j_expneurol_2024_114682 crossref_primary_10_1055_s_0044_1786681 crossref_primary_10_2147_IJN_S242787 crossref_primary_10_1002_SMMD_20220041 crossref_primary_10_3390_ijms25137151 crossref_primary_10_1002_mco2_313 crossref_primary_10_1016_j_matdes_2024_113202 crossref_primary_10_1016_j_nantod_2020_101030 crossref_primary_10_1021_acs_biomac_1c00440 crossref_primary_10_1002_adhm_202200143 crossref_primary_10_1021_acsnano_4c10053 crossref_primary_10_1021_acsnano_4c13562 crossref_primary_10_1016_j_mtbio_2022_100228 crossref_primary_10_3390_pharmaceutics14081589 crossref_primary_10_1007_s13346_023_01429_1 crossref_primary_10_1016_j_nantod_2024_102169 crossref_primary_10_1021_acsami_1c14189 crossref_primary_10_1016_j_jconrel_2025_01_018 crossref_primary_10_1080_17425247_2021_1960309 crossref_primary_10_1002_btm2_10278 crossref_primary_10_1080_10717544_2024_2425156 crossref_primary_10_1016_j_bioactmat_2021_08_010 crossref_primary_10_1080_26895293_2021_1967202 crossref_primary_10_1016_j_jconrel_2024_09_046 crossref_primary_10_32604_or_2022_025696 crossref_primary_10_3389_fcell_2021_686453 crossref_primary_10_1016_j_jconrel_2021_03_018 crossref_primary_10_1039_C9BM00926D crossref_primary_10_1016_j_pbiomolbio_2023_02_001 crossref_primary_10_1021_acsnano_4c16280 crossref_primary_10_1002_adhm_202304261 crossref_primary_10_1002_smll_202001588 crossref_primary_10_3390_jox14030047 crossref_primary_10_1002_adfm_202006169 crossref_primary_10_1016_j_cej_2019_123942 crossref_primary_10_1016_j_cellimm_2023_104771 crossref_primary_10_1016_j_mtbio_2023_100633 crossref_primary_10_1016_j_mtbio_2023_100751 crossref_primary_10_1039_D2BM02169B crossref_primary_10_3389_fmed_2021_721174 crossref_primary_10_3390_pharmaceutics16091113 crossref_primary_10_1016_j_ymthe_2020_01_018 crossref_primary_10_1007_s12015_022_10452_7 crossref_primary_10_1039_D0BM01731K crossref_primary_10_3390_pharmaceutics12050402 crossref_primary_10_58567_ci02020007 crossref_primary_10_1016_j_cej_2024_149641 crossref_primary_10_1016_j_jconrel_2020_12_054 crossref_primary_10_1002_smtd_202400096 crossref_primary_10_1016_j_ijpharm_2024_123923 crossref_primary_10_3390_pharmaceutics13060786 crossref_primary_10_1016_j_matdes_2020_109388 crossref_primary_10_1016_j_jconrel_2023_06_023 crossref_primary_10_1021_jacs_3c10295 crossref_primary_10_1016_j_ijpharm_2023_123069 crossref_primary_10_1186_s13287_023_03585_0 crossref_primary_10_1002_adtp_202100030 crossref_primary_10_1021_acsami_3c12560 crossref_primary_10_1038_s41392_023_01536_y crossref_primary_10_1002_EXP_20220045 crossref_primary_10_1186_s12951_021_01110_0 crossref_primary_10_1002_jbm_b_35348 crossref_primary_10_1186_s12951_022_01367_z crossref_primary_10_1016_j_jconrel_2020_06_037 crossref_primary_10_3389_fimmu_2024_1421854 crossref_primary_10_1016_j_cclet_2024_109576 crossref_primary_10_1002_smll_202304824 crossref_primary_10_26599_NTM_2022_9130007 crossref_primary_10_1016_j_ejphar_2022_175393 crossref_primary_10_34133_research_0478 crossref_primary_10_1016_j_nanoms_2021_12_001 crossref_primary_10_1038_s41575_021_00539_w crossref_primary_10_3390_molecules29081848 crossref_primary_10_1016_j_jconrel_2022_06_026 crossref_primary_10_1039_C9BM01401B crossref_primary_10_1016_j_nantod_2024_102414 crossref_primary_10_1039_D4CS00007B crossref_primary_10_3390_pharmaceutics15071821 crossref_primary_10_1002_smll_202401045 crossref_primary_10_1002_adhm_202300376 crossref_primary_10_1186_s12645_023_00215_5 crossref_primary_10_1016_j_cell_2020_02_001 crossref_primary_10_1016_j_ijpharm_2024_124753 crossref_primary_10_1016_j_jconrel_2022_09_012 crossref_primary_10_32604_biocell_2022_019363 crossref_primary_10_1016_j_nano_2024_102778 crossref_primary_10_1016_j_cej_2023_148120 crossref_primary_10_1016_j_jconrel_2023_07_004 crossref_primary_10_1039_C9BM01383K crossref_primary_10_3390_pharmaceutics13111888 crossref_primary_10_3389_fimmu_2023_1074863 crossref_primary_10_1016_j_celrep_2024_114579 crossref_primary_10_1039_D0CS00152J crossref_primary_10_3389_fbioe_2022_997799 crossref_primary_10_4103_epj_epj_188_22 crossref_primary_10_1186_s12951_022_01251_w crossref_primary_10_1002_adbi_201900260 crossref_primary_10_1016_j_jconrel_2024_06_017 crossref_primary_10_1038_s41565_024_01618_0 crossref_primary_10_1002_adma_202005295 crossref_primary_10_1002_adfm_202201013 crossref_primary_10_3390_biom13121787 crossref_primary_10_3390_ph17060707 crossref_primary_10_3390_pharmaceutics15072011 crossref_primary_10_1080_1061186X_2024_2347356 crossref_primary_10_1002_cmdc_202400410 crossref_primary_10_1002_smtd_202301178 crossref_primary_10_1016_j_engreg_2022_03_001 crossref_primary_10_1186_s13287_021_02602_4 crossref_primary_10_1039_D0BM01164A crossref_primary_10_1186_s13045_021_01208_w crossref_primary_10_1016_j_jconrel_2021_05_031 crossref_primary_10_1186_s12951_020_00649_8 crossref_primary_10_1021_acsnano_1c03800 crossref_primary_10_1007_s00216_025_05742_1 crossref_primary_10_1080_09205063_2022_2056942 crossref_primary_10_1007_s11033_020_05353_2 crossref_primary_10_1021_acsabm_4c00074 crossref_primary_10_2217_nnm_2022_0142 crossref_primary_10_1007_s12274_020_3265_z crossref_primary_10_3390_pharmaceutics15061677 crossref_primary_10_1016_j_ijpharm_2022_122084 crossref_primary_10_3389_fbioe_2022_796111 crossref_primary_10_1016_j_ymeth_2019_11_013 crossref_primary_10_3390_ijms241713511 crossref_primary_10_1016_j_biopha_2023_114451 crossref_primary_10_1016_j_aquaculture_2022_738535 crossref_primary_10_1016_j_semcancer_2022_04_007 crossref_primary_10_1002_btm2_10441 crossref_primary_10_1007_s13346_024_01605_x crossref_primary_10_1002_smtd_202200853 crossref_primary_10_1016_j_colsurfb_2024_113951 crossref_primary_10_1038_s41419_023_06110_6 crossref_primary_10_1002_adhm_202000893 crossref_primary_10_1016_j_nantod_2022_101577 crossref_primary_10_1039_D3NR06264C crossref_primary_10_1021_acsnano_3c12402 crossref_primary_10_1155_2021_1634782 crossref_primary_10_1016_j_colsurfb_2020_110879 crossref_primary_10_1016_j_jconrel_2025_113587 crossref_primary_10_1007_s12274_023_5470_z crossref_primary_10_1007_s13346_024_01591_0 crossref_primary_10_1080_10717544_2022_2100010 crossref_primary_10_1016_j_jconrel_2020_10_037 crossref_primary_10_1186_s12951_023_02060_5 crossref_primary_10_1002_wnan_1915 crossref_primary_10_1111_ejh_14014 crossref_primary_10_1021_acs_molpharmaceut_0c00421 crossref_primary_10_3390_pharmaceutics13081193 crossref_primary_10_1016_j_intimp_2024_113104 crossref_primary_10_1002_anbr_202400012 crossref_primary_10_1016_j_jconrel_2024_11_013 crossref_primary_10_1021_acsbiomaterials_2c01257 crossref_primary_10_1177_11795549241236896 crossref_primary_10_1016_j_brainres_2021_147522 crossref_primary_10_1080_10717544_2021_1934188 crossref_primary_10_1002_adhm_202401213 crossref_primary_10_1080_1061186X_2020_1757102 crossref_primary_10_1002_smtd_202301375 crossref_primary_10_1039_D4NH00457D crossref_primary_10_3390_molecules27082419 crossref_primary_10_1021_acsami_4c10098 crossref_primary_10_1016_j_jconrel_2021_09_018 crossref_primary_10_1159_000542356 crossref_primary_10_1007_s40820_019_0330_9 crossref_primary_10_1016_j_ijbiomac_2023_127055 crossref_primary_10_1039_D0BM01617A crossref_primary_10_1007_s11051_022_05482_8 crossref_primary_10_1186_s13287_023_03446_w |
| Cites_doi | 10.1038/s41467-018-06093-5 10.1021/mp400162k 10.4048/jbc.2012.15.3.273 10.1002/adhm.201500343 10.2147/IJN.S167142 10.1038/s41598-017-09175-4 10.1111/j.1582-4934.2008.00317.x 10.1186/1478-811X-9-12 10.1038/cddis.2013.19 10.1182/blood-2011-07-343566 10.1007/978-3-540-68976-8_12 10.1227/01.NEU.0000350227.61132.A7 10.1016/j.biomaterials.2016.10.033 10.1126/science.1148624 10.1089/hum.2012.104 10.1080/14653240410005267-1 10.1021/acsami.6b12865 10.1016/j.urolonc.2013.10.018 10.1016/j.jconrel.2010.05.015 10.1021/acsami.6b12829 10.1016/j.stem.2009.02.001 10.1038/srep44758 10.1039/C5RA17447C 10.1038/nature08956 10.3109/14653241003631815 10.1002/adfm.201200133 10.1186/s13287-015-0185-z 10.1002/smll.201600624 10.1038/aps.2013.50 10.1021/nl0624263 10.2217/nnm.12.153 10.1016/j.biomaterials.2015.10.046 10.2147/IJN.S109897 10.55782/ane-2013-1918 10.1016/j.nano.2013.06.003 10.1126/scitranslmed.aad2355 10.1158/0008-5472.CAN-12-3086 10.1634/stemcells.2006-0293 10.1186/s12885-015-1241-x 10.1016/j.surg.2009.04.013 10.1021/acs.nanolett.7b05263 10.1038/42218 10.1186/s13287-015-0140-z 10.1097/SLA.0b013e3181bd62d0 10.1021/nl401376w 10.1016/j.biomaterials.2014.03.062 10.18632/oncotarget.10758 10.1038/ncomms2766 10.1158/0008-5472.CAN-08-0451 10.1006/mthe.2001.0327 10.1016/S0003-4975(02)03591-9 10.1089/cbr.2011.1024 10.1016/j.bcp.2004.03.048 10.2174/1566523218666180413150023 10.1002/stem.665 10.1038/ncomms2282 10.1002/stem.2614 10.1002/adfm.201201733 10.1002/adma.201300638 10.1021/nl102184c 10.1016/j.addr.2018.06.012 10.1038/srep09073 10.1073/pnas.1412420111 10.1126/scitranslmed.3006839 10.1016/j.jconrel.2014.10.015 10.1073/pnas.1418230111 10.1038/nnano.2012.212 10.1634/stemcells.2003-0196 10.1002/jcb.22769 10.1158/1078-0432.CCR-07-0731 10.1021/mp300254s 10.1158/0008-5472.CAN-04-1874 10.1126/science.1229568 10.1158/1535-7163.MCT-07-0019 10.1182/blood-2006-05-025098 10.7243/2050-1218-2-4 10.1016/j.biomaterials.2014.09.014 10.1039/c3nr01541f 10.1016/j.biomaterials.2016.03.023 10.1166/jnn.2016.11730 10.1016/j.ijrobp.2008.06.1953 10.1634/stemcells.2007-0197 10.1167/iovs.13-12044 10.1210/me.2012-1019 10.1002/adma.200802789 10.1016/j.bbrc.2011.03.093 10.3892/ijmm.2012.1015 10.1016/j.ijpharm.2017.01.041 10.1227/01.NEU.0000345646.85472.EA 10.1073/pnas.1106634108 10.1016/j.jconrel.2015.05.007 10.1136/thoraxjnl-2013-204110 10.1002/adfm.201801355 10.1016/j.matlet.2015.02.079 10.1016/S0021-9258(17)33204-0 10.1002/stem.533 10.1002/hep.25716 10.1158/0008-5472.CAN-06-0040 10.1002/art.30203 10.1021/acsami.6b00853 10.1002/stem.436 10.1002/ijc.26278 10.1634/stemcells.2005-0271 10.1002/art.21753 10.1038/sj.mt.6300374 10.1038/gt.2008.39 10.1007/s00280-014-2498-5 10.1634/stemcells.2008-0831 10.1002/adma.201706759 10.1002/stem.1728 10.1093/jnci/djh299 10.1089/scd.2013.0249 10.1161/01.CIR.0000084828.50310.6A 10.1002/adma.201401550 10.1038/nature15373 10.1021/acs.nanolett.5b04237 10.2967/jnumed.114.146662 10.1038/ncomms13724 10.1634/stemcells.2004-0331 10.1166/jbn.2014.1712 10.1073/pnas.1309566110 10.1016/j.ymthe.2017.04.004 10.1016/j.scr.2011.05.002 10.1016/S0301-472X(02)00829-9 10.1039/c1cs15246g 10.1021/acsnano.5b02207 10.1038/sj.cgt.7701079 10.1016/S0301-472X(00)00134-X 10.1634/stemcells.2004-0058 10.7150/thno.14471 10.1111/bjh.12196 10.1016/j.jconrel.2012.07.034 10.1158/1078-0432.768.11.2 10.1056/NEJM198612253152606 10.1088/0957-4484/19/34/345606 10.1002/adma.201602173 10.1038/nature06188 10.1111/j.1349-7006.2010.01738.x 10.1097/SLA.0b013e3182368c4f 10.1016/j.ijpharm.2015.04.050 10.1080/2162402X.2016.1189052 10.1016/j.ijpharm.2017.08.073 10.1002/adma.201703969 10.1089/scd.2015.0103 10.1016/j.biomaterials.2016.06.057 10.1016/j.yjmcc.2008.03.010 10.1371/journal.pone.0190125 10.1371/journal.pone.0025663 10.1007/s13233-014-2184-9 10.1002/adfm.201501050 10.1016/j.jacc.2011.11.029 10.1021/acsnano.7b00133 10.1111/sji.12179 10.1038/emm.2013.94 10.1161/CIRCRESAHA.116.310374 10.1016/j.jconrel.2012.03.020 10.1126/scitranslmed.3003651 |
| ContentType | Journal Article |
| Copyright | 2018 Elsevier B.V. Copyright © 2018 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2018 Elsevier B.V. – notice: Copyright © 2018 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
| DOI | 10.1016/j.jconrel.2018.12.019 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE AGRICOLA MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1873-4995 |
| EndPage | 113 |
| ExternalDocumentID | 30553849 10_1016_j_jconrel_2018_12_019 S0168365918307223 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AABXZ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AATCM AAXUO ABFNM ABFRF ABJNI ABMAC ABOCM ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AEZYN AFKWA AFRZQ AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA HMT IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG RNS ROL RPZ SCC SDF SDG SDP SES SPC SPCBC SSM SSP SSZ T5K TEORI ~G- .GJ 29K 3O- AAHBH AAQXK AATTM AAXKI AAYOK AAYWO AAYXX ABWVN ABXDB ACNNM ACRPL ACVFH ADCNI ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION D-I FEDTE FGOYB G-2 HVGLF HZ~ R2- SEW SPT SSH WUQ CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
| ID | FETCH-LOGICAL-c501t-3137b6f9348be5c29df8566be2a75d41ebbc30ee65ed2f58ea0fb058e4b0d6733 |
| IEDL.DBID | .~1 |
| ISSN | 0168-3659 1873-4995 |
| IngestDate | Thu Jul 10 19:09:59 EDT 2025 Fri Jul 11 10:29:15 EDT 2025 Wed Feb 19 02:31:12 EST 2025 Tue Jul 01 04:04:43 EDT 2025 Thu Apr 24 23:09:46 EDT 2025 Fri Feb 23 02:49:01 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Nanoparticles Cell membrane-coating Mesenchymal stem cells Cell-based target drug delivery system |
| Language | English |
| License | Copyright © 2018 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c501t-3137b6f9348be5c29df8566be2a75d41ebbc30ee65ed2f58ea0fb058e4b0d6733 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0003-1052-7060 |
| PMID | 30553849 |
| PQID | 2157657495 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_2220853719 proquest_miscellaneous_2157657495 pubmed_primary_30553849 crossref_primary_10_1016_j_jconrel_2018_12_019 crossref_citationtrail_10_1016_j_jconrel_2018_12_019 elsevier_sciencedirect_doi_10_1016_j_jconrel_2018_12_019 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-01-28 |
| PublicationDateYYYYMMDD | 2019-01-28 |
| PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-28 day: 28 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Journal of controlled release |
| PublicationTitleAlternate | J Control Release |
| PublicationYear | 2019 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Hovatta, Stojkovic, Nogueira, Varela-Nieto (bb0090) 2010; 28 Caicedo, Fritz, Brondello, Ayala, Dennemont, Abdellaoui, de Fraipont, Moisan, Prouteau, Boukhaddaoui, Jorgensen, Vignais (bb0465) 2015; 5 Mohr, Albarenque, Deedigan, Yu, Reidy, Fulda, Zwacka (bb0145) 2010; 28 Karnoub, Dash, Vo, Sullivan, Brooks, Bell, Richardson, Polyak, Tubo, Weinberg (bb0900) 2007; 449 Wang, Gao, Ouyang, Wang, Sun, Lv (bb0545) 2018; 13 Reagan, Seib, Mcmillin, Sage, Mitsiades, Janes, Ghobrial, Kaplan (bb0675) 2012; 15 Bonomi, Silini, Vertua, Signoroni, Coccè, Cavicchini, Sisto, Alessandri, Pessina, Parolini (bb0515) 2015; 6 Li, Min, Jiang, Yin, Fu, Zhang, Hao, Zhang, Zhong, Hou (bb0120) 2017; 9 Zhang, Huang, Chen, Lian, Wang, Cai, Huang, Wang, Ren, Xiang (bb0355) 2017; 25 Riss, Khanna, Koo, Chandramouli, Yang, Hu, Kleiner, Rosenwald, Schaefer, Ben-Sasson, Yang, Powell, Kane, Star, Aprelikova, Bauer, Vasselli, Maranchie, Kohn, Buetow, Linehan, Weinstein, Lee, Klausner, Barrett (bb0295) 2006; 66 Albarenque, Zwacka, Mohr (bb0320) 2011; 7 Suila, Hirvonen, Kotovuori, Ritamo, Kerkela, Anderson, Natunen, Tuimala, Laitinen, Nystedt, Rabina, Valmu (bb0360) 2014; 80 Benny, Duvshani-Eshet, Cargioli, Bello, Bikfalvi, Carroll, Machluf (bb0865) 2005; 11 Zarbock, Ley, Mcever, Hidalgo (bb0485) 2011; 118 Chamberlain, Smith, Rainger, Middleton (bb0370) 2011; 6 Silva, Di Corato, Pellegrino, Chat, Pugliese, Luciani, Gazeau, Wilhelm (bb0805) 2013; 5 Hu, Huang, Zhang, Miao, Tang, Tabata, Gao (bb0645) 2012; 9 Pessina, Cocce, Pascucci, Bonomi, Cavicchini, Sisto, Ferrari, Ciusani, Crovace, Falchetti, Zicari, Caruso, Navone, Marfia, Benetti, Ceccarelli, Parati, Alessandri (bb0520) 2013; 160 Lee, Majumdar, Buyaner, Hendricks, Pittenger, Mosca (bb0605) 2001; 3 Nitzsche, Lukomska, Jolkkonen, Deten, Boltze (bb0365) 2017; 35 Peng, Niu, Zhang, Yu, Wu, Shan, Wang, Shen, Mao, Liang (bb0630) 2014; 35 Yang, Mao, Bao, Gao, Zhou, Xie, Zhou, Zhu (bb0325) 2009; 65 Jiahe, Yiwei, Lihua, Pengcheng, Sharkey, Qianhui, Brittany, Sweta, Xiling, King (bb0790) 2016; 76 Palumbo, Bianchi (bb0480) 2004; 68 S. Eliasof, D. Lazarus, C. Peters, R. Case, R. Cole, J. Hwang, T. Schluep, J. Chao, J. Lin, Y. Yen, H. Han, D. Wiley, J. Zuckerman, M. Davis, Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle, Proc. Natl. Acad. Sci. U. S. A., 110 (2013), pp. 15127-15132.m Lee, Kim, Ji, Kwon, Yong (bb0585) 2014; 22 Avolio, Gianfranceschi, Cesselli, Caragnano, Athanasakis, Katare, Meloni, Palma, Barchiesi, Vascotto (bb0875) 2015; 32 De Bari, Dell'Accio, Vanlauwe, Eyckmans, Khan, Archer, Jones, McGonagle, Mitsiadis, Pitzalis, Luyten (bb0285) 2006; 54 Müller, Schmohl, Knoop, Schug, Urnauer, Hagenhoff, Clevert, Ingrisch, Niess, Carlsen (bb0710) 2016; 7 Knoop, Schwenk, Dolp, Willhauck, Zischek, Zach, Hacker, Göke, Wagner, Nelson (bb0690) 2013; 24 Kim, Nam, Im, Lim, Lee, Jeon, Cho (bb0735) 2014; 16 Sotiropoulou, Perez, Salagianni, Baxevanis, Papamichail (bb0070) 2006; 24 Kim, Park, Na (bb0580) 2015; 36 Zhang, Huang, Yuan, Hu, Tabata, Gao (bb0135) 2014; 10 Mandel, Yang, Schambach, Glage, Otte, Hass (bb0470) 2013; 22 Friedenstein, Kulagina, Panasuk, Rudakowa, Luriá, Ruadkow (bb0100) 1974; 1974 Son, Marquez-Curtis, Kucia, Wysoczynski, Turner, Ratajczak, Ratajczak, Janowska-Wieczorek (bb0395) 2006; 24 Stein, Inic-Kanada, Belij, Montanaro, Bintner, Schlacher, Mayr, Lubitz, Stojanovic, Najdenski (bb0410) 2013; 54 Harold, Dvorak (bb0305) 1986; 315 Studeny, Champlin, Zompetta, Fidler, Andreeff (bb0230) 2002; 62 Xie, Peng, Shan, Niu, Xiong, Gao (bb0655) 2016; 16 Ashton, Nolan, Cadogan, Murray, Odedra, Foster, Hall, Low, Taylor, Ellston, Polanska, Wilson, Howes, Smith, Goodwin, Swales, Strittmatter, Takáts, Nilsson, Andren, Trueman, Walker, Reimer, Troiano, Parsons, De Witt, Ashford, Hrkach, Zale, Jewsbury, Barry (bb0005) 2016; 8 Xuan, Shao, Dai, He, Li (bb0420) 2015; 4 Wang, Ma, Ye, Liang, Yang, Guo, Li, Li, Liu (bb0590) 2012; 22 Fang, Kroll, Gao, Zhang (bb0265) 2018; 30 Gao, Lin, Jurado-Sanchez, Lin, Wu, He (bb0835) 2016; 12 Lai, Huang, Lin, Lin, Chang (bb0880) 2015; 5 Iacobuzio-Donahue, Argani, Hempen, Jones, Kern (bb0895) 2002; 62 U.S. National Library of Medicine (bb0495) 2018 Jensen, Ko, Hurley, Luciano, Kouri, Merkel, Luthi, Patel, Cutler, Daniel, Scott, Rotz, Meade, Giljohann, Mirkin, Stegh (bb0030) 2013; 5 Mohr, Lyons, Deedigan, Harte, Shaw, Howard, Barry, O'Brien, Zwacka (bb0165) 2008; 12 Aryal, Hu, Fang, Dehaini, Carpenter, Zhang, Zhang (bb0750) 2013; 8 Peng, Huang, Zhang, Niu, Chen, Chu, Jiang, Gao, Mao (bb0625) 2016; 103 Kim, Lim, Park, Jeong, Oh, Jeong, Oh, Park, Sung, Jeun (bb0240) 2008; 68 Hu, Fu, Tabata, Gao (bb0110) 2010; 147 Wei, Yang, Han, Qu, Shao, Shi (bb0095) 2013; 34 Diaz-Prado, Muinos-Lopez, Hermida-Gomez, Rendal-Vazquez, Fuentes-Boquete, de Toro, Blanco (bb0280) 2010; 111 Barenholz (bb0040) 2012; 160 Yao, Feng, Gao, Wei, Kang, Zhu, Jiang, Wei, Chen (bb0845) 2017; 113 Amano, Li, Gu, Gao, Koizumi, Yamamoto, Terakawa, Namba (bb0250) 2009; 35 Bi, Zhou, Liu, Lu, Lin, Xuan, Jiang, Han, Huang, Zhang, Dong, Liu, Huang, Xu (bb0390) 2014; 32 Luk, Fang, Hu, Copp, Thamphiwatana, Dehaini, Gao, Kang, Li, Zhang (bb0795) 2016; 6 Reagan, Seib, McMillin, Sage, Mitsiades, Janes, Ghobrial, Kaplan (bb0175) 2012; 15 Cheng, Ou, Zhou, Li, Jia, Zhang, Liu, Li, Ward, Melo, Kong (bb0345) 2008; 16 Conget, Minguell (bb0600) 2000; 28 Peng, Qi, Chen, Gao (bb0660) 2013; 352 Zhang, Cai, Li, Guo, Chen, He, Liu, Zhang, Lu, Chen, Sun, Huang, Cheng, Jiang (bb0830) 2018; 18 Steingen, Brenig, Baumgartner, Schmidt, Schmidt, Bloch (bb0435) 2008; 44 Knoop, Schwenk, Schmohl, Zach, Cyran, Carlsen, Bartenstein, Wagner, Nelson, Spitzweg (bb0695) 2015; 56 Murphy, Moncivais, Caplan (bb0270) 2013; 45 Wang, Wang, Abarbanell, Weil, Herrmann, Tan, Novotny, Coffey, Meldrum (bb0715) 2009; 146 Huang, Tabata, Gao (bb0105) 2012; 162 Hu, Fang, Wang, Luk, Thamphiwatana, Dehaini, Nguyen, Angsantikul, Wen, Kroll (bb0745) 2015; 526 Studeny, Marini, Champlin, Zompetta, Fidler, Andreeff (bb0730) 2002; 62 Gao, Lin, Wu, Lin, He (bb0815) 2016; 8 Chamberlain, Fox, Ashton, Middleton (bb0375) 2007; 25 Kanehira, Xin, Hoshino, Maemondo, Mizuguchi, Hayakawa, Matsumoto, Nakamura, Nukiwa, Saijo (bb0170) 2007; 14 Dwyer, Potter-Beirne, Harrington, Lowery, Hennessy, Murphy, Barry, O'Brien, Kerin (bb0450) 2007; 13 Barbash, Baron, Feinberg, Etzion, Tessone, Miller, Guetta, Zipori, Kedes, Kloner, Leor (bb0315) 2003; 108 Singh, Jain, Senapati, Verma, Sahoo (bb0570) 2015; 4 Li, Huang, Jiang, Chen, Ouyang, Gao (bb0125) 2018; 18 Anker, Kleijburg-van der Keur, de Groot-Swings, Claas, Fibbe, Kanhai (bb0290) 2004; 22 Hong, Savant-Bhonsale, Kalkanis (bb0330) 2009; 64 Nitzsche, Muller, Lukomska, Jolkkonen, Deten, Boltze (bb0890) 2017; 35 Levy, Brennen, Han, Rosen, Musabeyezu, Safaee, Ranganath, Ngai, Heinelt, Milton, Wang, Bhagchandani, Joshi, Bhowmick, Denmeade, Isaacs, Karp (bb0210) 2016; 91 Schenk, Mal, Finan, Zhang, Kiedrowski, Popovic, McCarthy, Penn (bb0455) 2007; 25 Brenner, Whiting-Theobald, Kawai, Linton, Rudikoff, Choi, Ryser, Murphy, Sechler, Malech (bb0350) 2004; 22 Tang, Zhang, Zhang, Xu, Liu, Ma, Lv, Li, Katirai, Shen (bb0405) 2012; 3 Thamphiwatana, Gao, Obonyo, Zhang (bb0780) 2014; 111 Gao, Hu, Fang, Luk, Su, Zhang (bb0825) 2013; 25 Yu, Deedigan, Albarenque, Mohr, Zwacka (bb0195) 2013; 4 Kholodenko, Konieva, Kholodenko, Yarygin (bb0335) 2013; 2 Kim, Kim, Jeong, Kim, Kim, Jeon, Kwon, Jeun, Yang, Oh, Chang (bb0380) 2011; 407 Li, Cheng, Malliaras, Smith, Zhang, Sun, Matsushita, Blusztajn, Terrovitis (bb0870) 2012; 59 Shinojima, Hossain, Takezaki, Fueyo, Gumin, Feng, Nwajei, Marini, Andreeff, Kuratsu (bb0475) 2013; 73 Nowakowski, Andrzejewska, Janowski, Walczak, Lukomska (bb0670) 2013; 73 Serakinci, Christensen, Fahrioglu, Sorensen, Dagnaes-Hansen, Hajek, Jensen, Kolvraa, Keith (bb0190) 2011; 26 Hall, Andreeff, Marini (bb0300) 2007; 180 Toledano Furman, Lupu-Haber, Bronshtein, Kaneti, Letko, Weinstein, Baruch, Machluf (bb0850) 2013; 13 Li, Ruan, Huangfu, Chen, Liu, Li, Hu, Han, Davidson, Levkin (bb0620) 2015; 488 Nandi, Shapiro, Samur, Pai, Frank, Yoon, Prabhala, Munshi, Gold (bb0460) 2016; 5 Dwyer, Ryan, Havelin, Morris, Miller, Liu, Flavin, O'Flatharta, Foley, Barrett, Murphy, Barry, O'Brien, Kerin (bb0185) 2011; 29 Rodriguez, Christian, Pantano, Richard, Tsai (bb0065) 2013; 339 Sadhukha, O'Brien, Prabha (bb0535) 2014; 196 Sotiropoulou, Perez, Salagianni, Baxevanis, Papamichail (bb0500) 2010; 24 Kidd, Caldwell, Dietrich, Samudio, Spaeth, Watson, Shi, Abbruzzese, Konopleva, Andreeff, Marini (bb0155) 2010; 12 Anker, Scherjon, Kleijburg-van der Keur, de Groot-Swings, Claas, Fibbe, Kanhai (bb0510) 2004; 22 Huang, Neretina, Elsayed (bb0555) 2010; 21 Lu, Hung, Hsiao, Yao, Chung, Lin, Wu, Hsu, Liu, Mou (bb0595) 2007; 7 Xuan, Shao, Dai, Li, He (bb0820) 2016; 8 Jadzinsky, Calero, Ackerson, Bushnell, Kornberg (bb0055) 2007; 318 Chen, Cheng, Yin, He, Yang, Wei, Chen (bb0160) 2012; 30 Rao, Cai, Bu, Liao, Guo, Zhao, Dong, Liu (bb0800) 2017; 11 Li, Barnes, Bosoy, Stoddart, Zink (bb0060) 2012; 43 Shegokar, Shaal (bb0080) 2016 Peng, Wei, Qi, Shan, Zhang, Chen, Zhu, Yu, Liang, Gao (bb0665) 2013; 10 Altanerova, Cihova, Babic, Rychly, Ondicova, Mravec, Altaner (bb0245) 2012; 130 Wan, Yao, Faiola, Liu, Zhang, Tabata, Mizuguchi, Nakagawa, Gao, Zhao (bb0610) 2016; 11 Hu, Huang, Zhang, Miao, Tang, Tabata, Gao (bb0680) 2012; 9 Steer, ML (bb0740) 1976; 251 Hu, Miao, Huang, Zhang, Hu, Tabata, Gao (bb0140) 2014; 10 Compte, Cuesta, Sanchez-Martin, Alonso-Camino, Vicario, Sanz, Alvarez-Vallina (bb0085) 2009; 27 Zhang, Huang, Yuan, Hu, Tabata, Gao (bb0640) 2014; 10 Bryzgunova, Vlassov, Laktionov (bb0860) 2007; 6 Rieck, Zhang, Li, Liu, Naji, Takane, Fiaschi-Taesch, Stewart, Kushner, Kaestner (bb0215) 2012; 26 Niess, von Einem, Thomas, Michl, Angele, Huss, Gunther, Nelson, Bruns, Heinemann (bb0725) 2015; 15 Cao, Yang, Zhu, Qu, Mao (bb0550) 2014; 26 Aldridge, Garg, Davies, Bartlett, Youster, Beard, Kavanagh, Kalia, Frampton, Lalor (bb0430) 2012; 56 Wang, Hu, Wang, Fu (bb0205) 2012; 40 Hu, Zhang, Aryal, Cheung, Fang, Zhang (bb0765) 2011; 108 Parodi, Quattrocchi, Al, Jeong (10.1016/j.jconrel.2018.12.019_bb0010) 1997; 388 Kim (10.1016/j.jconrel.2018.12.019_bb0240) 2008; 68 Wang (10.1016/j.jconrel.2018.12.019_bb0445) 2002; 30 Saito (10.1016/j.jconrel.2018.12.019_bb0505) 2002; 74 Rodriguez (10.1016/j.jconrel.2018.12.019_bb0065) 2013; 339 Pacioni (10.1016/j.jconrel.2018.12.019_bb0530) 2015; 6 Mohr (10.1016/j.jconrel.2018.12.019_bb0145) 2010; 28 Zhang (10.1016/j.jconrel.2018.12.019_bb0830) 2018; 18 Serakinci (10.1016/j.jconrel.2018.12.019_bb0190) 2011; 26 Lu (10.1016/j.jconrel.2018.12.019_bb0595) 2007; 7 Zielske (10.1016/j.jconrel.2018.12.019_bb0200) 2009; 75 Lee (10.1016/j.jconrel.2018.12.019_bb0605) 2001; 3 Sotiropoulou (10.1016/j.jconrel.2018.12.019_bb0070) 2006; 24 Benny (10.1016/j.jconrel.2018.12.019_bb0865) 2005; 11 Karnoub (10.1016/j.jconrel.2018.12.019_bb0900) 2007; 449 Hu (10.1016/j.jconrel.2018.12.019_bb0765) 2011; 108 Kim (10.1016/j.jconrel.2018.12.019_bb0255) 2015; 24 Anker (10.1016/j.jconrel.2018.12.019_bb0290) 2004; 22 Santos (10.1016/j.jconrel.2018.12.019_bb0340) 2011; 63 Fang (10.1016/j.jconrel.2018.12.019_bb0265) 2018; 30 Hu (10.1016/j.jconrel.2018.12.019_bb0745) 2015; 526 De Bari (10.1016/j.jconrel.2018.12.019_bb0285) 2006; 54 Ashton (10.1016/j.jconrel.2018.12.019_bb0005) 2016; 8 Wang (10.1016/j.jconrel.2018.12.019_bb0715) 2009; 146 Kim (10.1016/j.jconrel.2018.12.019_bb0735) 2014; 16 Kang (10.1016/j.jconrel.2018.12.019_bb0560) 2015; 9 Suila (10.1016/j.jconrel.2018.12.019_bb0360) 2014; 80 Peng (10.1016/j.jconrel.2018.12.019_bb0630) 2014; 35 Gao (10.1016/j.jconrel.2018.12.019_bb0815) 2016; 8 Steer (10.1016/j.jconrel.2018.12.019_bb0740) 1976; 251 Chamberlain (10.1016/j.jconrel.2018.12.019_bb0370) 2011; 6 Wang (10.1016/j.jconrel.2018.12.019_bb0590) 2012; 22 Chen (10.1016/j.jconrel.2018.12.019_bb0160) 2012; 30 Kaneti (10.1016/j.jconrel.2018.12.019_bb0855) 2016; 16 Murphy (10.1016/j.jconrel.2018.12.019_bb0270) 2013; 45 Conget (10.1016/j.jconrel.2018.12.019_bb0600) 2000; 28 Wu (10.1016/j.jconrel.2018.12.019_bb0760) 2015; 25 Li (10.1016/j.jconrel.2018.12.019_bb0870) 2012; 59 Tan (10.1016/j.jconrel.2018.12.019_bb0415) 2015; 5 Zhang (10.1016/j.jconrel.2018.12.019_bb0640) 2014; 10 Kidd (10.1016/j.jconrel.2018.12.019_bb0155) 2010; 12 Kroll (10.1016/j.jconrel.2018.12.019_bb0755) 2017; 29 Sage (10.1016/j.jconrel.2018.12.019_bb0260) 2014; 69 Yao (10.1016/j.jconrel.2018.12.019_bb0615) 2014; 447 Bryzgunova (10.1016/j.jconrel.2018.12.019_bb0860) 2007; 6 Almeida (10.1016/j.jconrel.2018.12.019_bb0385) 2016; 6 Dwyer (10.1016/j.jconrel.2018.12.019_bb0450) 2007; 13 Rao (10.1016/j.jconrel.2018.12.019_bb0800) 2017; 11 Albarenque (10.1016/j.jconrel.2018.12.019_bb0320) 2011; 7 Compte (10.1016/j.jconrel.2018.12.019_bb0085) 2009; 27 Steingen (10.1016/j.jconrel.2018.12.019_bb0435) 2008; 44 Chamberlain (10.1016/j.jconrel.2018.12.019_bb0375) 2007; 25 Zischek (10.1016/j.jconrel.2018.12.019_bb0720) 2009; 250 Diaz-Prado (10.1016/j.jconrel.2018.12.019_bb0280) 2010; 111 Hovatta (10.1016/j.jconrel.2018.12.019_bb0090) 2010; 28 Shinojima (10.1016/j.jconrel.2018.12.019_bb0475) 2013; 73 Brenner (10.1016/j.jconrel.2018.12.019_bb0350) 2004; 22 Barbash (10.1016/j.jconrel.2018.12.019_bb0315) 2003; 108 Zhang (10.1016/j.jconrel.2018.12.019_bb0635) 2017; 520 Schenk (10.1016/j.jconrel.2018.12.019_bb0455) 2007; 25 Thamphiwatana (10.1016/j.jconrel.2018.12.019_bb0780) 2014; 111 Shi (10.1016/j.jconrel.2018.12.019_bb0020) 2010; 10 Cheng (10.1016/j.jconrel.2018.12.019_bb0345) 2008; 16 Hu (10.1016/j.jconrel.2018.12.019_bb0110) 2010; 147 Nitzsche (10.1016/j.jconrel.2018.12.019_bb0890) 2017; 35 Finally (10.1016/j.jconrel.2018.12.019_bb0705) 2017; 2017 Xie (10.1016/j.jconrel.2018.12.019_bb0655) 2016; 16 Hong (10.1016/j.jconrel.2018.12.019_bb0330) 2009; 64 Stein (10.1016/j.jconrel.2018.12.019_bb0410) 2013; 54 Spaeth (10.1016/j.jconrel.2018.12.019_bb0440) 2008; 15 Luk (10.1016/j.jconrel.2018.12.019_bb0795) 2016; 6 Zhang (10.1016/j.jconrel.2018.12.019_bb0130) 2015; 209 Peng (10.1016/j.jconrel.2018.12.019_bb0660) 2013; 352 Kim (10.1016/j.jconrel.2018.12.019_bb0580) 2015; 36 Palumbo (10.1016/j.jconrel.2018.12.019_bb0480) 2004; 68 Hall (10.1016/j.jconrel.2018.12.019_bb0300) 2007; 180 Zischek (10.1016/j.jconrel.2018.12.019_bb0150) 2009; 250 Hu (10.1016/j.jconrel.2018.12.019_bb0645) 2012; 9 Tang (10.1016/j.jconrel.2018.12.019_bb0770) 2017; 8 Hu (10.1016/j.jconrel.2018.12.019_bb0140) 2014; 10 Son (10.1016/j.jconrel.2018.12.019_bb0395) 2006; 24 Li (10.1016/j.jconrel.2018.12.019_bb0225) 2010; 101 Peng (10.1016/j.jconrel.2018.12.019_bb0625) 2016; 103 Avolio (10.1016/j.jconrel.2018.12.019_bb0875) 2015; 32 Zarbock (10.1016/j.jconrel.2018.12.019_bb0485) 2011; 118 Nakamizo (10.1016/j.jconrel.2018.12.019_bb0235) 2005; 65 Xuan (10.1016/j.jconrel.2018.12.019_bb0820) 2016; 8 Li (10.1016/j.jconrel.2018.12.019_bb0060) 2012; 43 Huang (10.1016/j.jconrel.2018.12.019_bb0115) 2017; 531 Li (10.1016/j.jconrel.2018.12.019_bb0125) 2018; 18 Cheng (10.1016/j.jconrel.2018.12.019_bb0575) 2013; 23 Gao (10.1016/j.jconrel.2018.12.019_bb0825) 2013; 25 Müller (10.1016/j.jconrel.2018.12.019_bb0710) 2016; 7 Kim (10.1016/j.jconrel.2018.12.019_bb0380) 2011; 407 Iacobuzio-Donahue (10.1016/j.jconrel.2018.12.019_bb0895) 2002; 62 Caicedo (10.1016/j.jconrel.2018.12.019_bb0465) 2015; 5 Shegokar (10.1016/j.jconrel.2018.12.019_bb0080) 2016 Ahn (10.1016/j.jconrel.2018.12.019_bb0045) 2014; 74 U.S. National Library of Medicine (10.1016/j.jconrel.2018.12.019_bb0495) Sotiropoulou (10.1016/j.jconrel.2018.12.019_bb0500) 2010; 24 Reagan (10.1016/j.jconrel.2018.12.019_bb0175) 2012; 15 Aryal (10.1016/j.jconrel.2018.12.019_bb0750) 2013; 8 Lai (10.1016/j.jconrel.2018.12.019_bb0880) 2015; 5 Riss (10.1016/j.jconrel.2018.12.019_bb0295) 2006; 66 Nitzsche (10.1016/j.jconrel.2018.12.019_bb0365) 2017; 35 Bi (10.1016/j.jconrel.2018.12.019_bb0390) 2014; 32 Silva (10.1016/j.jconrel.2018.12.019_bb0805) 2013; 5 Thanuja (10.1016/j.jconrel.2018.12.019_bb0075) 2018; 132 Aldridge (10.1016/j.jconrel.2018.12.019_bb0430) 2012; 56 10.1016/j.jconrel.2018.12.019_bb0810 Anker (10.1016/j.jconrel.2018.12.019_bb0510) 2004; 22 Li (10.1016/j.jconrel.2018.12.019_bb0120) 2017; 9 Yao (10.1016/j.jconrel.2018.12.019_bb0845) 2017; 113 Jadzinsky (10.1016/j.jconrel.2018.12.019_bb0055) 2007; 318 Pessina (10.1016/j.jconrel.2018.12.019_bb0520) 2013; 160 Gao (10.1016/j.jconrel.2018.12.019_bb0835) 2016; 12 Knoop (10.1016/j.jconrel.2018.12.019_bb0690) 2013; 24 Studeny (10.1016/j.jconrel.2018.12.019_bb0180) 2004; 96 Wang (10.1016/j.jconrel.2018.12.019_bb0205) 2012; 40 Wan (10.1016/j.jconrel.2018.12.019_bb0610) 2016; 11 Sage (10.1016/j.jconrel.2018.12.019_bb0685) 2014; 69 Reagan (10.1016/j.jconrel.2018.12.019_bb0675) 2012; 15 Li (10.1016/j.jconrel.2018.12.019_bb0885) 2008; 19 Jensen (10.1016/j.jconrel.2018.12.019_bb0030) 2013; 5 Li (10.1016/j.jconrel.2018.12.019_bb0650) 2015; 148 Zhang (10.1016/j.jconrel.2018.12.019_bb0135) 2014; 10 Rieck (10.1016/j.jconrel.2018.12.019_bb0215) 2012; 26 Parodi (10.1016/j.jconrel.2018.12.019_bb0425) 2013; 8 Toledano Furman (10.1016/j.jconrel.2018.12.019_bb0850) 2013; 13 Davis (10.1016/j.jconrel.2018.12.019_bb0025) 2010; 464 Zhang (10.1016/j.jconrel.2018.12.019_bb0355) 2017; 25 Nandi (10.1016/j.jconrel.2018.12.019_bb0460) 2016; 5 Friedenstein (10.1016/j.jconrel.2018.12.019_bb0100) 1974; 1974 Dwyer (10.1016/j.jconrel.2018.12.019_bb0185) 2011; 29 Coccè (10.1016/j.jconrel.2018.12.019_bb0525) 2017; 7 Lee (10.1016/j.jconrel.2018.12.019_bb0585) 2014; 22 Kanehira (10.1016/j.jconrel.2018.12.019_bb0170) 2007; 14 Xuan (10.1016/j.jconrel.2018.12.019_bb0420) 2015; 4 Niess (10.1016/j.jconrel.2018.12.019_bb0725) 2015; 15 Levy (10.1016/j.jconrel.2018.12.019_bb0210) 2016; 91 Yang (10.1016/j.jconrel.2018.12.019_bb0325) 2009; 65 Bonomi (10.1016/j.jconrel.2018.12.019_bb0515) 2015; 6 Xue (10.1016/j.jconrel.2018.12.019_bb0015) 2018; 9 Huang (10.1016/j.jconrel.2018.12.019_bb0105) 2012; 162 Nowakowski (10.1016/j.jconrel.2018.12.019_bb0670) 2013; 73 Wei (10.1016/j.jconrel.2018.12.019_bb0095) 2013; 34 Yu (10.1016/j.jconrel.2018.12.019_bb0195) 2013; 4 Ruster (10.1016/j.jconrel.2018.12.019_bb0490) 2006; 108 Hass (10.1016/j.jconrel.2018.12.019_bb0275) 2011; 9 10.1016/j.jconrel.2018.12.019_bb0035 Kuroki (10.1016/j.jconrel.2018.12.019_bb0700) 2017; 12 Copp (10.1016/j.jconrel.2018.12.019_bb0785) 2014; 111 Wang (10.1016/j.jconrel.2018.12.019_bb0545) 2018; 13 Peng (10.1016/j.jconrel.2018.12.019_bb0665) 2013; 10 Sun (10.1016/j.jconrel.2018.12.019_bb0840) 2016; 28 Sadhukha (10.1016/j.jconrel.2018.12.019_bb0535) 2014; 196 Frank (10.1016/j.jconrel.2018.12.019_bb0565) 2004; 6 Studeny (10.1016/j.jconrel.2018.12.019_bb0730) 2002; 62 Cao (10.1016/j.jconrel.2018.12.019_bb0550) 2014; 26 Jung (10.1016/j.jconrel.2018.12.019_bb0400) 2013; 4 Jiahe (10.1016/j.jconrel.2018.12.019_bb0790) 2016; 76 Barenholz (10.1016/j.jconrel.2018.12.019_bb0040) 2012; 160 Mohr (10.1016/j.jconrel.2018.12.019_bb0165) 2008; 12 Altanerova (10.1016/j.jconrel.2018.12.019_bb0245) 2012; 130 Harold (10.1016/j.jconrel.2018.12.019_bb0305) 1986; 315 Knoop (10.1016/j.jconrel.2018.12.019_bb0695) 2015; 56 Luo (10.1016/j.jconrel.2018.12.019_bb0775) 2017; 120 Niess (10.1016/j.jconrel.2018.12.019_bb0220) 2011; 254 Amano (10.1016/j.jconrel.2018.12.019_bb0250) 2009; 35 Zhao (10.1016/j.jconrel.2018.12.019_bb0540) 2017; 7 Hrkach (10.1016/j.jconrel.2018.12.019_bb0050) 2012; 4 Karp (10.1016/j.jconrel.2018.12.019_bb0310) 2009; 4 Huang (10.1016/j.jconrel.2018.12.019_bb0555) 2010; 21 Li (10.1016/j.jconrel.2018.12.019_bb0620) 2015; 488 Mandel (10.1016/j.jconrel.2018.12.019_bb0470) 2013; 22 Kholodenko (10.1016/j.jconrel.2018.12.019_bb0335) 2013; 2 Hu (10.1016/j.jconrel.2018.12.019_bb0680) 2012; 9 Studeny (10.1016/j.jconrel.2018.12.019_bb0230) 2002; 62 Tang (10.1016/j.jconrel.2018.12.019_bb0405) 2012; 3 Singh (10.1016/j.jconrel.2018.12.019_bb0570) 2015; 4 |
| References_xml | – volume: 54 start-page: 1209 year: 2006 end-page: 1221 ident: bb0285 article-title: Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis publication-title: Arthritis Rheum. – volume: 13 start-page: 3248 year: 2013 end-page: 3255 ident: bb0850 article-title: Reconstructed stem cell nanoghosts: a natural tumor targeting platform publication-title: Nano Lett. – volume: 6 start-page: 621 year: 2004 end-page: 625 ident: bb0565 article-title: Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging publication-title: Cytotherapy – volume: 2017 start-page: 1 year: 2017 end-page: 10 ident: bb0705 article-title: Cells, human menstrual blood-derived mesenchymal stem cells as potential cell carriers for oncolytic adenovirus publication-title: Stem Cells Int. – volume: 180 start-page: 263 year: 2007 end-page: 283 ident: bb0300 article-title: The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles publication-title: Handb. Exp. Pharmacol. – volume: 6 start-page: 466 year: 2016 end-page: 473 ident: bb0385 article-title: NAP-2 secreted by human NK cells can stimulate mesenchymal stem/stromal cell recruitment publication-title: Stem Cells – volume: 488 start-page: 1 year: 2015 end-page: 11 ident: bb0620 article-title: ScreenFect A: an efficient and low toxic liposome for gene delivery to mesenchymal stem cells publication-title: Int. J. Pharm. – volume: 108 start-page: 10980 year: 2011 end-page: 10985 ident: bb0765 article-title: Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform publication-title: Natl. cad. Sci. U. S. A. – volume: 5 start-page: 863 year: 2015 end-page: 881 ident: bb0415 article-title: Cell or cell membrane-based drug delivery systems publication-title: Adv. Mater. – volume: 25 start-page: 3881 year: 2015 end-page: 3887 ident: bb0760 article-title: Cell membrane coated synthetic nanomotors for effective biodetoxification publication-title: Adv. Fun. Mater. – volume: 35 start-page: 1446 year: 2017 end-page: 1460 ident: bb0890 article-title: Concise review: MSC adhesion cascade-insights into homing and transendothelial migration publication-title: Stem Cells – volume: 29 start-page: 1018 year: 2017 end-page: 1026 ident: bb0755 article-title: Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity publication-title: Adv. Mater. – volume: 5 start-page: 11374 year: 2013 end-page: 11384 ident: bb0805 article-title: Cell-derived vesicles as a bioplatform for the encapsulation of theranostic nanomaterials publication-title: Nanoscale – volume: 2 start-page: 1 year: 2013 end-page: 4 ident: bb0335 article-title: Molecular mechanisms of migration and homing of intravenously transplanted mesenchymal stem cells publication-title: J. Regener. Med. Tissue Eng. – volume: 6 start-page: 1004 year: 2016 end-page: 1011 ident: bb0795 article-title: Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors publication-title: Theranostics – volume: 111 start-page: 17600 year: 2014 end-page: 17605 ident: bb0780 article-title: In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation publication-title: Proc. Natl. Acad. Sci. U. S. A. – reference: F. Fontana, S. Albertini, A. Correia, M. Kemell, R. Lindgren, E. Mäkilä, J. Salonen, J.T. Hirvonen, F. Ferrari, H.A. Santos, Bioengineered porous silicon nanoparticles@macrophages cell membrane as composite platforms for rheumatoid arthritis, Adv. Func. Mater., 28 (2018) online. – volume: 15 start-page: 273 year: 2012 end-page: 282 ident: bb0675 article-title: Stem cell implants for cancer therapy: TRAIL-expressing mesenchymal stem cells target cancer cells in situ publication-title: J. Breast Cancer – volume: 26 start-page: 4627 year: 2014 end-page: 4631 ident: bb0550 article-title: Stem cells loaded with nanoparticles as a drug carrier for in vivo breast cancer therapy publication-title: Adv. Mater. – volume: 9 start-page: 3653 year: 2018 ident: bb0015 article-title: Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment publication-title: Nat. Commun. – volume: 8 start-page: 1271 year: 2013 end-page: 1280 ident: bb0750 article-title: Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release publication-title: Nanomedicine – volume: 32 start-page: 2373 year: 2015 end-page: 2385 ident: bb0875 article-title: Ex vivo molecular rejuvenation improves the therapeutic activity of senescent human cardiac stem cells in a mouse model of myocardial infarction publication-title: Stem Cells – volume: 28 start-page: 1005 year: 2010 end-page: 1007 ident: bb0090 article-title: European scientific, ethical, and legal issues on human stem cell research and regenerative medicine publication-title: Stem Cells – volume: 24 start-page: 1254 year: 2006 end-page: 1264 ident: bb0395 article-title: Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases publication-title: Stem Cells – volume: 4 start-page: 2078 year: 2015 end-page: 2089 ident: bb0570 article-title: Magnetic nanoparticles labeled mesenchymal stem cells: a pragmatic solution toward targeted cancer theranostics publication-title: Adv. Healthc. Mater. – volume: 146 start-page: 198 year: 2009 end-page: 205 ident: bb0715 article-title: MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells publication-title: Surgery – volume: 318 start-page: 430 year: 2007 end-page: 433 ident: bb0055 article-title: Structure of a thiol monolayer-protected gold nanoparticle at 1.1 A resolution publication-title: Science – volume: 96 start-page: 1593 year: 2004 end-page: 1603 ident: bb0180 article-title: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents publication-title: J. Natl. Cancer Inst. – volume: 196 start-page: 243 year: 2014 end-page: 251 ident: bb0535 article-title: Nano-engineered mesenchymal stem cells as targeted therapeutic carriers publication-title: J Control. Rel. – volume: 24 start-page: 306 year: 2013 end-page: 316 ident: bb0690 article-title: Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma publication-title: Hum. Gene. Ther. – volume: 24 start-page: 2808 year: 2015 end-page: 2821 ident: bb0255 article-title: IL-21 expressing mesenchymal stem cells prevent lethal B-Cell lymphoma through efficient delivery of IL-21, which redirects the immune system totarget the tumor publication-title: Stem Cells Dev. – volume: 40 start-page: 317 year: 2012 end-page: 327 ident: bb0205 article-title: Mesenchymal stem cells modified to express interferon-β inhibit the growth of prostate cancer in a mouse model publication-title: J. In. Med. Res. – volume: 22 start-page: 2363 year: 2012 end-page: 2375 ident: bb0590 article-title: Protamine functionalized single-walled carbon nanotubes for stem cell labeling and in vivo raman/magnetic resonance/photoacoustic triple-modal imaging publication-title: Adv. Func. Mater. – volume: 69 start-page: 638 year: 2014 end-page: 647 ident: bb0685 article-title: Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma publication-title: Thorax – volume: 11 start-page: 768 year: 2005 ident: bb0865 article-title: Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth publication-title: Clin. Cancer Res. – volume: 9 start-page: 12 year: 2011 ident: bb0275 article-title: Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC publication-title: Cell Commun. Signal. – volume: 8 start-page: 34252 year: 2016 end-page: 34260 ident: bb0815 article-title: Stem-cell-membrane camouflaging on near-infrared photoactivated upconversion nanoarchitectures for in vivo remote-controlled photodynamic therapy publication-title: ACS Appl. Mater. Interfaces – volume: 531 start-page: 90 year: 2017 end-page: 100 ident: bb0115 article-title: Peptide modified mesenchymal stem cells as targeting delivery system transfected with miR-133b for the treatment of cerebral ischemia publication-title: Int. J. Pharm. – volume: 35 start-page: 1265 year: 2009 end-page: 1270 ident: bb0250 article-title: Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy publication-title: Int. J. Oncol. – volume: 26 start-page: 767 year: 2011 end-page: 773 ident: bb0190 article-title: Mesenchymal stem cells as therapeutic delivery vehicles targeting tumor stroma publication-title: Cancer Biother. Radiopharm. – volume: 73 start-page: 2333 year: 2013 end-page: 2344 ident: bb0475 article-title: TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells publication-title: Cancer Res. – volume: 21 start-page: 4880 year: 2010 end-page: 4910 ident: bb0555 article-title: Gold nanorods: from synthesis and properties to biological and biomedical applications publication-title: Adv. Mater. – volume: 4 start-page: 1795 year: 2013 ident: bb0400 article-title: Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis publication-title: Nat. Commun. – volume: 64 start-page: 1139 year: 2009 end-page: 1146 ident: bb0330 article-title: Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model publication-title: Neurosurgery – volume: 407 start-page: 741 year: 2011 end-page: 746 ident: bb0380 article-title: CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas publication-title: Biochem. Biophys. Res. Commun. – volume: 108 start-page: 3938 year: 2006 end-page: 3944 ident: bb0490 article-title: Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells publication-title: Blood – volume: 9 start-page: 2698 year: 2012 ident: bb0645 article-title: Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection publication-title: Mol. Pharm. – volume: 22 start-page: 1128 year: 2004 end-page: 1133 ident: bb0350 article-title: CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells publication-title: Stem Cells – volume: 68 start-page: 1165 year: 2004 end-page: 1170 ident: bb0480 article-title: High mobility group box 1 protein, a cue for stem cell recruitment publication-title: Biochem. Pharmacol. – volume: 209 start-page: 260 year: 2015 end-page: 271 ident: bb0130 article-title: Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice publication-title: J Control. Rel. – volume: 10 start-page: 3223 year: 2010 end-page: 3230 ident: bb0020 article-title: Nanotechnology in drug delivery and tissue engineering: from discovery to applications publication-title: Nano Lett. – volume: 18 start-page: 29 year: 2018 end-page: 39 ident: bb0125 article-title: Transplantation of BDNF gene recombinant mesenchymal stem cells and adhesive peptide-modified hydrogel scaffold for spinal cord repair publication-title: Curr. Gene Ther. – volume: 35 start-page: 1446 year: 2017 end-page: 1460 ident: bb0365 article-title: Concise review: MSC adhesion cascade—insights into homing and transendothelial migration publication-title: Stem Cells – volume: 111 start-page: 846 year: 2010 end-page: 857 ident: bb0280 article-title: Multilineage differentiation potential of cells isolated from the human amniotic membrane publication-title: J. Cell Biochem. – volume: 5 start-page: 209 year: 2013 ident: bb0030 article-title: Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma publication-title: Sci. Transl. Med. – volume: 3 start-page: 1282 year: 2012 ident: bb0405 article-title: Delivery of chemotherapeutic drugs in tumour cell-derived microparticles publication-title: Nat. Commun. – volume: 352 start-page: 573 year: 2013 end-page: 583 ident: bb0660 article-title: Transplantation of bone-marrow-derived mesenchymal and epidermal stem;cells contribute to wound healing with different regenerative features publication-title: Mol. Pharm. – volume: 7 start-page: 149 year: 2007 ident: bb0595 article-title: Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling publication-title: Nano Lett. – volume: 12 year: 2017 ident: bb0700 article-title: Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer publication-title: Plos One – volume: 3 start-page: 857 year: 2001 end-page: 866 ident: bb0605 article-title: Human mesenchymal stem cells maintain transgene expression during expansion and differentiation publication-title: Mol. Ther. – volume: 5 year: 2016 ident: bb0460 article-title: Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages publication-title: Oncoimmunology – reference: S. Eliasof, D. Lazarus, C. Peters, R. Case, R. Cole, J. Hwang, T. Schluep, J. Chao, J. Lin, Y. Yen, H. Han, D. Wiley, J. Zuckerman, M. Davis, Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle, Proc. Natl. Acad. Sci. U. S. A., 110 (2013), pp. 15127-15132.m,, – volume: 147 start-page: 154 year: 2010 end-page: 162 ident: bb0110 article-title: Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy publication-title: J Control. Rel. – volume: 23 start-page: 272 year: 2013 end-page: 280 ident: bb0575 article-title: Multifunctional upconversion nanoparticles for dual-Modal imaging-guided stem cell therapy under remote magnetic control publication-title: Adv. Func. Mater. – volume: 36 start-page: 90 year: 2015 end-page: 97 ident: bb0580 article-title: Gadolinium-chelate nanoparticle entrapped human mesenchymal stem cell via photochemical internalization for cancer diagnosis publication-title: Biomaterials – volume: 19 start-page: 345606 year: 2008 ident: bb0885 article-title: An efficient and user-friendly method for the synthesis of hexagonal-phase NaYF(4):Yb, Er/Tm nanocrystals with controllable shape and upconversion fluorescence publication-title: Nanotechnology – volume: 69 start-page: 638 year: 2014 end-page: 647 ident: bb0260 article-title: Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma publication-title: Thorax – volume: 27 start-page: 753 year: 2009 end-page: 760 ident: bb0085 article-title: Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds publication-title: Stem Cells – volume: 18 start-page: 1908 year: 2018 end-page: 1915 ident: bb0830 article-title: Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy publication-title: Nano Lett. – volume: 65 start-page: 610 year: 2009 end-page: 624 ident: bb0325 article-title: Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosisinducing, ligand-engineered human mesenchymal stem cells publication-title: Neurosurgery – volume: 16 start-page: 571 year: 2008 end-page: 579 ident: bb0345 article-title: Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance publication-title: Mol. Ther. – volume: 160 start-page: 766 year: 2013 end-page: 778 ident: bb0520 article-title: Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice publication-title: Br. J. Haematol. – volume: 35 start-page: 5605 year: 2014 end-page: 5618 ident: bb0630 article-title: TAT conjugated cationic noble metal nanoparticles for gene delivery to epidermal stem cells publication-title: Biomaterials – volume: 447 start-page: 383 year: 2014 end-page: 387 ident: bb0615 article-title: Polyethyleneimine-coating enhances adenoviral transduction of mesenchymal stem cells publication-title: Res. Commun. – volume: 4 year: 2013 ident: bb0195 article-title: Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects publication-title: Cell Death Dis. – volume: 75 start-page: 843 year: 2009 end-page: 853 ident: bb0200 article-title: Radiation increases invasion of gene-modified mesenchymal stem cells into tumors publication-title: Int. J. Radiat. Oncol. Biol. Phys. – volume: 16 start-page: 1574 year: 2016 ident: bb0855 article-title: Nanoghosts as a novel natural nonviral gene delivery platform safely targeting multiple cancers publication-title: Nano Lett. – volume: 160 start-page: 117 year: 2012 end-page: 134 ident: bb0040 article-title: Doxil(R)--the first FDA-approved nano-drug: lessons learned publication-title: J. Control. Release – volume: 148 start-page: 96 year: 2015 end-page: 98 ident: bb0650 article-title: Design of cell niches for the regulation of stem cell fate in central nervous tissue regeneration publication-title: Mater. Lette. – volume: 132 start-page: 57 year: 2018 end-page: 80 ident: bb0075 article-title: Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far publication-title: Adv. Drug Deliv. Rev. – volume: 45 year: 2013 ident: bb0270 article-title: Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine publication-title: Exp. Mol. Med. – volume: 80 start-page: 12 year: 2014 end-page: 21 ident: bb0360 article-title: Human umbilical cord blood-derived mesenchymal stromal cells display a novel interaction between P-selectin and galectin-1 publication-title: Scand. J. Immunol. – volume: 56 start-page: 1063 year: 2012 end-page: 1073 ident: bb0430 article-title: Human mesenchymal stem cells are recruited to injured liver in a β1-integrin and CD44 dependent manner publication-title: Hepatology – volume: 74 start-page: 277 year: 2014 end-page: 282 ident: bb0045 article-title: A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer publication-title: Cancer Chemother. Pharmacol. – volume: 118 start-page: 6743 year: 2011 ident: bb0485 article-title: Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow publication-title: Blood – volume: 339 start-page: 971 year: 2013 end-page: 975 ident: bb0065 article-title: Minimal self peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles publication-title: Science – volume: 13 start-page: 5020 year: 2007 end-page: 5027 ident: bb0450 article-title: Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells publication-title: Clin. Cancer Res. – volume: 10 start-page: 3090 year: 2013 end-page: 3102 ident: bb0665 article-title: Epidermal stem cells manipulated by pDNA-VEGF165/CYD-PEI nanoparticles loaded gelatin/beta-TCP matrix as a therapeutic agent and gene delivery vehicle for wound healing publication-title: Mol. Pharm. – volume: 24 start-page: 462 year: 2010 end-page: 471 ident: bb0500 article-title: Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells publication-title: Stem Cells – volume: 7 start-page: 44758 year: 2017 ident: bb0540 article-title: Targeted delivery of doxorubicin by nano-loaded mesenchymal stem cells for lung melanoma metastases therapy publication-title: Sci. Rep. – volume: 14 start-page: 894 year: 2007 end-page: 903 ident: bb0170 article-title: Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells publication-title: Cancer Gene Ther. – volume: 449 start-page: 557 year: 2007 end-page: 563 ident: bb0900 article-title: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis publication-title: Nature – volume: 62 start-page: 3603 year: 2002 end-page: 3608 ident: bb0730 article-title: Bone Marrow-derived Mesenchymal Stem Cells as Vehicles for Interferon-β Delivery into Tumors publication-title: J. Control. Rel. – volume: 43 start-page: 2590 year: 2012 end-page: 2605 ident: bb0060 article-title: Mesoporous silica nanoparticles in biomedical applications publication-title: Chem. Soc. Rev. – volume: 59 start-page: 942 year: 2012 end-page: 953 ident: bb0870 article-title: Kusuoka, Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells publication-title: J. Am. Coll. Cardiol. – volume: 4 start-page: 206 year: 2009 end-page: 216 ident: bb0310 article-title: Mesenchymal stem cell homing: the devil is in the details publication-title: Cell Stem Cell – volume: 63 start-page: 960 year: 2011 end-page: 970 ident: bb0340 article-title: Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice publication-title: Arthritis Rheum. – volume: 25 start-page: 1434 year: 2017 end-page: 1447 ident: bb0355 article-title: CXCR5-overexpressing mesenchymal stromal cells exhibit enhanced homing and can decrease contact hypersensitivity publication-title: Mol. Ther. – volume: 9 start-page: 3330 year: 2017 ident: bb0120 article-title: Interfaces, Peptide-tethered hydrogel scaffold promotes recovery from spinal cord transection via synergism with mesenchymal stem cells publication-title: ACS Appl. Mater. Interfaces – volume: 526 start-page: 118 year: 2015 end-page: 121 ident: bb0745 article-title: Nanoparticle biointerfacing by platelet membrane cloaking publication-title: Nature – volume: 65 start-page: 3307 year: 2005 end-page: 3318 ident: bb0235 article-title: Human bone marrow–derived mesenchymal stem cells in the treatment of gliomas publication-title: Cancer Res. – volume: 6 start-page: 155 year: 2015 ident: bb0515 article-title: Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study publication-title: Stem Cell Res. Ther. – volume: 10 start-page: 257 year: 2014 end-page: 267 ident: bb0135 article-title: Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection publication-title: Nanomedicine:Nanotechnology Biology and Medicine – volume: 520 start-page: 1 year: 2017 end-page: 13 ident: bb0635 article-title: Design of magnetic gene complexes as effective and serum resistant gene delivery systems for mesenchymal stem cells publication-title: Int. J. Pharm. – volume: 10 start-page: 299 year: 2014 end-page: 308 ident: bb0140 article-title: Reversal of tumor growth by gene modification of mesenchymal stem cells using spermine-pullulan/DNA nanoparticles publication-title: J. Biomed. Nanotechnol. – volume: 8 start-page: 9610 year: 2016 end-page: 9618 ident: bb0820 article-title: Macrophage cell membrane camouflaged Au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy publication-title: ACS Appl. Mater. Interfaces – volume: 68 start-page: 9614 year: 2008 end-page: 9623 ident: bb0240 article-title: Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma publication-title: Cancer Res. – volume: 56 start-page: 600 year: 2015 end-page: 606 ident: bb0695 article-title: Mesenchymal stem cell (MSC)-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene publication-title: J. Nucl. Med. – volume: 24 start-page: 462 year: 2006 end-page: 471 ident: bb0070 article-title: Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells publication-title: Stem Cells – volume: 15 start-page: 273 year: 2012 end-page: 282 ident: bb0175 article-title: Stem cell implants for cancer therapy: TRAIL-Expressing mesenchymal stem cells target cancer cells in situ publication-title: J. Breast Cancer – volume: 113 start-page: 1 year: 2017 end-page: 17 ident: bb0845 article-title: Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer publication-title: Biomaterials – volume: 7 start-page: 163 year: 2011 end-page: 171 ident: bb0320 article-title: Both human and mouse mesenchymal stem cells promote breast cancer metastasis publication-title: Stem Cell Res. – volume: 4 year: 2015 ident: bb0420 article-title: Macrophage cell membrane camouflaged mesoporous silica nanocapsules for in vivo cancer therapy publication-title: Adv. Healthcare Mater. – volume: 9 start-page: 9678 year: 2015 ident: bb0560 article-title: Mesenchymal stem cells aggregate and deliver gold nanoparticles to tumors for photothermal therapy publication-title: ACS Nano – volume: 54 start-page: 6326 year: 2013 end-page: 6333 ident: bb0410 article-title: In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: cell-based delivery system to target ocular surface diseases publication-title: Invest. Ophthalmol. Vis. Sci. – volume: 108 start-page: 863 year: 2003 end-page: 868 ident: bb0315 article-title: Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution publication-title: Circulation – volume: 22 start-page: 1141 year: 2014 end-page: 1151 ident: bb0585 article-title: Molecular imaging for in vivo tracking of stem cell fate publication-title: Macromol. Res. – volume: 30 year: 2018 ident: bb0265 article-title: Cell membrane coating nanotechnology publication-title: Adv. Mater. – volume: 91 start-page: 140 year: 2016 end-page: 150 ident: bb0210 article-title: A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer publication-title: Biomaterials – volume: 11 start-page: 3496 year: 2017 end-page: 3505 ident: bb0800 article-title: Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy publication-title: ACS Nano – volume: 30 start-page: 527 year: 2012 end-page: 534 ident: bb0160 article-title: Therapeutic potential of bone marrow-derived mesenchymal stem cells producing pigment epithelium-derived factor in lung carcinoma publication-title: Int. J. Mol. Med. – volume: 15 start-page: 237 year: 2015 ident: bb0725 article-title: Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial publication-title: BMC Cancer – volume: 8 year: 2016 ident: bb0005 article-title: Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo publication-title: Sci. Transl. Med. – volume: 29 start-page: 1149 year: 2011 end-page: 1157 ident: bb0185 article-title: Mesenchymal stem cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer publication-title: Stem Cells – volume: 16 year: 2014 ident: bb0735 article-title: IL-21-expressing mesenchymal stem cells prevent lethal B-cell lymphoma through efficient delivery of IL-21, which redirects the immune system to target the tumor publication-title: Stem Cells Dev. – volume: 315 start-page: 1650 year: 1986 end-page: 1659 ident: bb0305 article-title: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing publication-title: N. Engl. J. of medicine – volume: 22 start-page: 1338 year: 2004 end-page: 1345 ident: bb0510 article-title: Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta publication-title: Stem Cells – volume: 32 start-page: 607 year: 2014 end-page: 612 ident: bb0390 article-title: Kidney cancer cells secrete IL-8 to activate Akt and promote migration of mesenchymal stem cells publication-title: Urol. Oncol. – year: 2018 ident: bb0495 article-title: Clinical Trails on MSCs – volume: 10 start-page: 257 year: 2014 end-page: 267 ident: bb0640 article-title: Medicine, Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection publication-title: Nanomedicine – volume: 464 start-page: 1067 year: 2010 end-page: 1070 ident: bb0025 article-title: Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles publication-title: Nature – volume: 250 start-page: 747 year: 2009 end-page: 753 ident: bb0720 article-title: Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma publication-title: Ann. Surg. – volume: 7 start-page: 9376 year: 2017 ident: bb0525 article-title: Drug loaded gingival mesenchymal stromal cells (GinPa-MSCs) inhibit in vitro proliferation of oral squamous cell carcinoma publication-title: Sci. Rep. – start-page: 325 year: 2016 end-page: 346 ident: bb0080 article-title: Applications of cell-based drug delivery systems: use of single cell assay publication-title: Essentials of Single-cell Analysis – volume: 6 year: 2011 ident: bb0370 article-title: Mesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shear publication-title: PLoS One – volume: 73 start-page: 1 year: 2013 end-page: 18 ident: bb0670 article-title: Genetic engineering of stem cells for enhanced therapy publication-title: Acta. Neurobiol. Exp. – volume: 111 start-page: 13481 year: 2014 end-page: 134866 ident: bb0785 article-title: Clearance of pathological antibodies using biomimetic nanoparticles publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 34 start-page: 747 year: 2013 end-page: 754 ident: bb0095 article-title: Mesenchymal stem cells: a new trend for cell therapy publication-title: Acta Pharmaco. Sin. – volume: 66 start-page: 7216 year: 2006 end-page: 7224 ident: bb0295 article-title: Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma publication-title: Cancer Res. – volume: 8 start-page: 61 year: 2013 ident: bb0425 article-title: Biomimetic functionalization with leukocyte membranes imparts cell like functions to synthetic particles publication-title: Nat. Nanotechnol. – volume: 22 start-page: 3114 year: 2013 end-page: 3127 ident: bb0470 article-title: Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo publication-title: Stem Cells Dev. – volume: 26 start-page: 1590 year: 2012 end-page: 1602 ident: bb0215 article-title: Overexpression of hepatocyte nuclear factor-4alpha initiates cell cycle entry, but is not sufficient to promote beta-cell expansion in human islets publication-title: Mol. Endocrinol. – volume: 15 start-page: 730 year: 2008 end-page: 738 ident: bb0440 article-title: Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells publication-title: Gene Ther. – volume: 62 start-page: 3603 year: 2002 end-page: 3608 ident: bb0230 article-title: Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors publication-title: Cancer Res. – volume: 4 start-page: 128ra139 year: 2012 ident: bb0050 article-title: Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile publication-title: Sci. Transl. Med. – volume: 251 start-page: 4930 year: 1976 end-page: 4935 ident: bb0740 article-title: Preparation and characterization of hormone-sensitive, resealed etythrocyte ghosts publication-title: J. Biol. Chem. – volume: 6 start-page: 194 year: 2015 ident: bb0530 article-title: Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts publication-title: Stem Cell Res. Ther. – volume: 28 start-page: 2109 year: 2010 end-page: 2120 ident: bb0145 article-title: Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells publication-title: Stem Cells – volume: 25 start-page: 2739 year: 2007 end-page: 2749 ident: bb0375 article-title: Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing publication-title: Stem Cells – volume: 25 start-page: 245 year: 2007 end-page: 251 ident: bb0455 article-title: Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor publication-title: Stem Cells – volume: 120 start-page: 1768 year: 2017 end-page: 1775 ident: bb0775 article-title: Fabrication of Synthetic Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice publication-title: Circ. Res. – volume: 25 start-page: 3549 year: 2013 end-page: 3553 ident: bb0825 article-title: Surface functionalization of gold nanoparticles with red blood cell membranes publication-title: Adv. Mater. – volume: 101 start-page: 2546 year: 2010 end-page: 2553 ident: bb0225 article-title: Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line publication-title: Cancer Sci. – volume: 9 start-page: 2698 year: 2012 end-page: 2709 ident: bb0680 article-title: Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection publication-title: Mol. Pham. – volume: 8 start-page: 13724 year: 2017 ident: bb0770 article-title: Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome publication-title: Nat. Commun. – volume: 162 start-page: 464 year: 2012 end-page: 473 ident: bb0105 article-title: Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases publication-title: J. Control. Rel. – volume: 130 start-page: 2455 year: 2012 end-page: 2463 ident: bb0245 article-title: Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase:uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma publication-title: Int. J. Cancer – volume: 254 start-page: 767 year: 2011 end-page: 774 ident: bb0220 article-title: Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma publication-title: Ann. Surg. – volume: 30 start-page: 831 year: 2002 end-page: 836 ident: bb0445 article-title: Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture publication-title: Exp. Hematol. – volume: 388 start-page: 860 year: 1997 ident: bb0010 article-title: Biodegradable block copolymers as injectable drug-delivery systems publication-title: Nature – volume: 62 start-page: 5351 year: 2002 ident: bb0895 article-title: The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types publication-title: Cancer Res. – volume: 12 start-page: 615 year: 2010 end-page: 625 ident: bb0155 article-title: Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment publication-title: Cytotherapy – volume: 74 start-page: 19 year: 2002 end-page: 24 ident: bb0505 article-title: Xenotransplant cardiac chimera: immune tolerance of adult stem cells publication-title: Ann. Thorac. Surg. – volume: 13 start-page: 5231 year: 2018 end-page: 5248 ident: bb0545 article-title: Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy publication-title: Int. J. Nanomed. – volume: 28 start-page: 9581 year: 2016 end-page: 9588 ident: bb0840 article-title: Cancer cell biomimetic nanoparticles for targeted therapy of homotypic tumors publication-title: Adv. Mater. – volume: 250 start-page: 747 year: 2009 end-page: 753 ident: bb0150 article-title: Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma publication-title: Ann. Surg. – volume: 12 start-page: 2628 year: 2008 end-page: 2643 ident: bb0165 article-title: Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model publication-title: J. Cell Mol. Med. – volume: 11 start-page: 6763 year: 2016 end-page: 6769 ident: bb0610 article-title: Coating with spermine-pullulan polymer enhances adenoviral transduction of mesenchymal stem cells publication-title: Int. J. Nanomed. – volume: 12 start-page: 4056 year: 2016 end-page: 4062 ident: bb0835 article-title: Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery publication-title: Small – volume: 5 start-page: 98222 year: 2015 end-page: 98230 ident: bb0880 article-title: Biomimetic stem cell membrane-camouflaged iron oxide nanoparticles for theranostic applications publication-title: RSC Adv. – volume: 28 start-page: 382 year: 2000 end-page: 390 ident: bb0600 article-title: Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells publication-title: Exp. Hemotol. – volume: 1974 start-page: 83 year: 1974 end-page: 92 ident: bb0100 article-title: Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method publication-title: Exp. Hematol. – volume: 22 start-page: 1338 year: 2004 end-page: 1345 ident: bb0290 article-title: Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta publication-title: Stem cells – volume: 44 start-page: 1072 year: 2008 end-page: 1084 ident: bb0435 article-title: Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells publication-title: J. Mol. Cell Cardiol. – volume: 7 start-page: 54795 year: 2016 end-page: 54810 ident: bb0710 article-title: Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery publication-title: Oncotarget – volume: 76 start-page: 52 year: 2016 end-page: 65 ident: bb0790 article-title: Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles publication-title: Biomaterials – volume: 6 start-page: 2371 year: 2007 ident: bb0860 article-title: Therapeutic ultrasound facilitates antiangiogenic gene delivery and inhibits prostate tumor growth publication-title: Mol. Cancer Ther. – volume: 103 start-page: 137 year: 2016 end-page: 149 ident: bb0625 article-title: Integration of antimicrobial peptides with gold nanoparticles as unique non-viral vectors for gene delivery to mesenchymal stem cells with antibacterial activity publication-title: Biomaterials – volume: 16 start-page: 5498 year: 2016 end-page: 5505 ident: bb0655 article-title: Adult stem cells seeded on electrospinning silk fibroin nanofiberous scaffold enhance wound repair and regeneration publication-title: J. Nanosci. Nanotechnol. – volume: 5 start-page: 9073 year: 2015 ident: bb0465 article-title: MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function publication-title: Sci. Rep. – volume: 9 start-page: 3653 year: 2018 ident: 10.1016/j.jconrel.2018.12.019_bb0015 article-title: Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment publication-title: Nat. Commun. doi: 10.1038/s41467-018-06093-5 – volume: 1974 start-page: 83 year: 1974 ident: 10.1016/j.jconrel.2018.12.019_bb0100 article-title: Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method publication-title: Exp. Hematol. – volume: 10 start-page: 3090 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0665 article-title: Epidermal stem cells manipulated by pDNA-VEGF165/CYD-PEI nanoparticles loaded gelatin/beta-TCP matrix as a therapeutic agent and gene delivery vehicle for wound healing publication-title: Mol. Pharm. doi: 10.1021/mp400162k – volume: 15 start-page: 273 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0675 article-title: Stem cell implants for cancer therapy: TRAIL-expressing mesenchymal stem cells target cancer cells in situ publication-title: J. Breast Cancer doi: 10.4048/jbc.2012.15.3.273 – volume: 4 start-page: 2078 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0570 article-title: Magnetic nanoparticles labeled mesenchymal stem cells: a pragmatic solution toward targeted cancer theranostics publication-title: Adv. Healthc. Mater. doi: 10.1002/adhm.201500343 – volume: 13 start-page: 5231 year: 2018 ident: 10.1016/j.jconrel.2018.12.019_bb0545 article-title: Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S167142 – volume: 7 start-page: 9376 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0525 article-title: Drug loaded gingival mesenchymal stromal cells (GinPa-MSCs) inhibit in vitro proliferation of oral squamous cell carcinoma publication-title: Sci. Rep. doi: 10.1038/s41598-017-09175-4 – volume: 12 start-page: 2628 year: 2008 ident: 10.1016/j.jconrel.2018.12.019_bb0165 article-title: Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model publication-title: J. Cell Mol. Med. doi: 10.1111/j.1582-4934.2008.00317.x – volume: 9 start-page: 12 year: 2011 ident: 10.1016/j.jconrel.2018.12.019_bb0275 article-title: Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC publication-title: Cell Commun. Signal. doi: 10.1186/1478-811X-9-12 – volume: 4 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0195 article-title: Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects publication-title: Cell Death Dis. doi: 10.1038/cddis.2013.19 – volume: 118 start-page: 6743 year: 2011 ident: 10.1016/j.jconrel.2018.12.019_bb0485 article-title: Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow publication-title: Blood doi: 10.1182/blood-2011-07-343566 – volume: 180 start-page: 263 year: 2007 ident: 10.1016/j.jconrel.2018.12.019_bb0300 article-title: The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles publication-title: Handb. Exp. Pharmacol. doi: 10.1007/978-3-540-68976-8_12 – volume: 65 start-page: 610 year: 2009 ident: 10.1016/j.jconrel.2018.12.019_bb0325 article-title: Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosisinducing, ligand-engineered human mesenchymal stem cells publication-title: Neurosurgery doi: 10.1227/01.NEU.0000350227.61132.A7 – volume: 113 start-page: 1 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0845 article-title: Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer publication-title: Biomaterials doi: 10.1016/j.biomaterials.2016.10.033 – volume: 318 start-page: 430 year: 2007 ident: 10.1016/j.jconrel.2018.12.019_bb0055 article-title: Structure of a thiol monolayer-protected gold nanoparticle at 1.1 A resolution publication-title: Science doi: 10.1126/science.1148624 – volume: 24 start-page: 306 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0690 article-title: Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma publication-title: Hum. Gene. Ther. doi: 10.1089/hum.2012.104 – volume: 6 start-page: 621 year: 2004 ident: 10.1016/j.jconrel.2018.12.019_bb0565 article-title: Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging publication-title: Cytotherapy doi: 10.1080/14653240410005267-1 – volume: 8 start-page: 34252 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0815 article-title: Stem-cell-membrane camouflaging on near-infrared photoactivated upconversion nanoarchitectures for in vivo remote-controlled photodynamic therapy publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.6b12865 – volume: 62 start-page: 3603 year: 2002 ident: 10.1016/j.jconrel.2018.12.019_bb0230 article-title: Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors publication-title: Cancer Res. – volume: 32 start-page: 607 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0390 article-title: Kidney cancer cells secrete IL-8 to activate Akt and promote migration of mesenchymal stem cells publication-title: Urol. Oncol. doi: 10.1016/j.urolonc.2013.10.018 – volume: 147 start-page: 154 year: 2010 ident: 10.1016/j.jconrel.2018.12.019_bb0110 article-title: Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy publication-title: J Control. Rel. doi: 10.1016/j.jconrel.2010.05.015 – volume: 9 start-page: 3330 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0120 article-title: Interfaces, Peptide-tethered hydrogel scaffold promotes recovery from spinal cord transection via synergism with mesenchymal stem cells publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.6b12829 – volume: 4 start-page: 206 year: 2009 ident: 10.1016/j.jconrel.2018.12.019_bb0310 article-title: Mesenchymal stem cell homing: the devil is in the details publication-title: Cell Stem Cell doi: 10.1016/j.stem.2009.02.001 – volume: 7 start-page: 44758 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0540 article-title: Targeted delivery of doxorubicin by nano-loaded mesenchymal stem cells for lung melanoma metastases therapy publication-title: Sci. Rep. doi: 10.1038/srep44758 – volume: 5 start-page: 98222 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0880 article-title: Biomimetic stem cell membrane-camouflaged iron oxide nanoparticles for theranostic applications publication-title: RSC Adv. doi: 10.1039/C5RA17447C – volume: 464 start-page: 1067 year: 2010 ident: 10.1016/j.jconrel.2018.12.019_bb0025 article-title: Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles publication-title: Nature doi: 10.1038/nature08956 – volume: 12 start-page: 615 year: 2010 ident: 10.1016/j.jconrel.2018.12.019_bb0155 article-title: Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment publication-title: Cytotherapy doi: 10.3109/14653241003631815 – volume: 22 start-page: 2363 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0590 article-title: Protamine functionalized single-walled carbon nanotubes for stem cell labeling and in vivo raman/magnetic resonance/photoacoustic triple-modal imaging publication-title: Adv. Func. Mater. doi: 10.1002/adfm.201200133 – volume: 5 start-page: 863 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0415 article-title: Cell or cell membrane-based drug delivery systems publication-title: Adv. Mater. – volume: 6 start-page: 194 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0530 article-title: Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts publication-title: Stem Cell Res. Ther. doi: 10.1186/s13287-015-0185-z – volume: 12 start-page: 4056 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0835 article-title: Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery publication-title: Small doi: 10.1002/smll.201600624 – volume: 34 start-page: 747 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0095 article-title: Mesenchymal stem cells: a new trend for cell therapy publication-title: Acta Pharmaco. Sin. doi: 10.1038/aps.2013.50 – volume: 7 start-page: 149 year: 2007 ident: 10.1016/j.jconrel.2018.12.019_bb0595 article-title: Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling publication-title: Nano Lett. doi: 10.1021/nl0624263 – volume: 8 start-page: 1271 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0750 article-title: Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release publication-title: Nanomedicine doi: 10.2217/nnm.12.153 – volume: 76 start-page: 52 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0790 article-title: Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles publication-title: Biomaterials doi: 10.1016/j.biomaterials.2015.10.046 – volume: 11 start-page: 6763 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0610 article-title: Coating with spermine-pullulan polymer enhances adenoviral transduction of mesenchymal stem cells publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S109897 – volume: 73 start-page: 1 issue: 1 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0670 article-title: Genetic engineering of stem cells for enhanced therapy publication-title: Acta. Neurobiol. Exp. doi: 10.55782/ane-2013-1918 – volume: 447 start-page: 383 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0615 article-title: Polyethyleneimine-coating enhances adenoviral transduction of mesenchymal stem cells publication-title: Res. Commun. – volume: 10 start-page: 257 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0640 article-title: Medicine, Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection publication-title: Nanomedicine doi: 10.1016/j.nano.2013.06.003 – volume: 8 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0005 article-title: Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aad2355 – volume: 73 start-page: 2333 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0475 article-title: TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-3086 – volume: 25 start-page: 245 year: 2007 ident: 10.1016/j.jconrel.2018.12.019_bb0455 article-title: Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor publication-title: Stem Cells doi: 10.1634/stemcells.2006-0293 – volume: 15 start-page: 237 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0725 article-title: Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial publication-title: BMC Cancer doi: 10.1186/s12885-015-1241-x – volume: 16 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0735 article-title: IL-21-expressing mesenchymal stem cells prevent lethal B-cell lymphoma through efficient delivery of IL-21, which redirects the immune system to target the tumor publication-title: Stem Cells Dev. – volume: 146 start-page: 198 year: 2009 ident: 10.1016/j.jconrel.2018.12.019_bb0715 article-title: MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells publication-title: Surgery doi: 10.1016/j.surg.2009.04.013 – volume: 18 start-page: 1908 year: 2018 ident: 10.1016/j.jconrel.2018.12.019_bb0830 article-title: Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy publication-title: Nano Lett. doi: 10.1021/acs.nanolett.7b05263 – volume: 388 start-page: 860 year: 1997 ident: 10.1016/j.jconrel.2018.12.019_bb0010 article-title: Biodegradable block copolymers as injectable drug-delivery systems publication-title: Nature doi: 10.1038/42218 – volume: 6 start-page: 155 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0515 article-title: Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study publication-title: Stem Cell Res. Ther. doi: 10.1186/s13287-015-0140-z – volume: 250 start-page: 747 year: 2009 ident: 10.1016/j.jconrel.2018.12.019_bb0150 article-title: Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma publication-title: Ann. Surg. doi: 10.1097/SLA.0b013e3181bd62d0 – volume: 13 start-page: 3248 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0850 article-title: Reconstructed stem cell nanoghosts: a natural tumor targeting platform publication-title: Nano Lett. doi: 10.1021/nl401376w – volume: 35 start-page: 5605 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0630 article-title: TAT conjugated cationic noble metal nanoparticles for gene delivery to epidermal stem cells publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.03.062 – volume: 7 start-page: 54795 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0710 article-title: Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery publication-title: Oncotarget doi: 10.18632/oncotarget.10758 – volume: 40 start-page: 317 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0205 article-title: Mesenchymal stem cells modified to express interferon-β inhibit the growth of prostate cancer in a mouse model publication-title: J. In. Med. Res. – volume: 4 start-page: 1795 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0400 article-title: Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis publication-title: Nat. Commun. doi: 10.1038/ncomms2766 – volume: 68 start-page: 9614 year: 2008 ident: 10.1016/j.jconrel.2018.12.019_bb0240 article-title: Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-0451 – volume: 3 start-page: 857 year: 2001 ident: 10.1016/j.jconrel.2018.12.019_bb0605 article-title: Human mesenchymal stem cells maintain transgene expression during expansion and differentiation publication-title: Mol. Ther. doi: 10.1006/mthe.2001.0327 – volume: 35 start-page: 1265 year: 2009 ident: 10.1016/j.jconrel.2018.12.019_bb0250 article-title: Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy publication-title: Int. J. Oncol. – volume: 15 start-page: 273 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0175 article-title: Stem cell implants for cancer therapy: TRAIL-Expressing mesenchymal stem cells target cancer cells in situ publication-title: J. Breast Cancer doi: 10.4048/jbc.2012.15.3.273 – volume: 74 start-page: 19 year: 2002 ident: 10.1016/j.jconrel.2018.12.019_bb0505 article-title: Xenotransplant cardiac chimera: immune tolerance of adult stem cells publication-title: Ann. Thorac. Surg. doi: 10.1016/S0003-4975(02)03591-9 – volume: 26 start-page: 767 year: 2011 ident: 10.1016/j.jconrel.2018.12.019_bb0190 article-title: Mesenchymal stem cells as therapeutic delivery vehicles targeting tumor stroma publication-title: Cancer Biother. Radiopharm. doi: 10.1089/cbr.2011.1024 – volume: 68 start-page: 1165 year: 2004 ident: 10.1016/j.jconrel.2018.12.019_bb0480 article-title: High mobility group box 1 protein, a cue for stem cell recruitment publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2004.03.048 – volume: 18 start-page: 29 year: 2018 ident: 10.1016/j.jconrel.2018.12.019_bb0125 article-title: Transplantation of BDNF gene recombinant mesenchymal stem cells and adhesive peptide-modified hydrogel scaffold for spinal cord repair publication-title: Curr. Gene Ther. doi: 10.2174/1566523218666180413150023 – volume: 29 start-page: 1149 year: 2011 ident: 10.1016/j.jconrel.2018.12.019_bb0185 article-title: Mesenchymal stem cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer publication-title: Stem Cells doi: 10.1002/stem.665 – volume: 3 start-page: 1282 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0405 article-title: Delivery of chemotherapeutic drugs in tumour cell-derived microparticles publication-title: Nat. Commun. doi: 10.1038/ncomms2282 – volume: 35 start-page: 1446 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0890 article-title: Concise review: MSC adhesion cascade-insights into homing and transendothelial migration publication-title: Stem Cells doi: 10.1002/stem.2614 – volume: 23 start-page: 272 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0575 article-title: Multifunctional upconversion nanoparticles for dual-Modal imaging-guided stem cell therapy under remote magnetic control publication-title: Adv. Func. Mater. doi: 10.1002/adfm.201201733 – volume: 25 start-page: 3549 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0825 article-title: Surface functionalization of gold nanoparticles with red blood cell membranes publication-title: Adv. Mater. doi: 10.1002/adma.201300638 – volume: 10 start-page: 3223 year: 2010 ident: 10.1016/j.jconrel.2018.12.019_bb0020 article-title: Nanotechnology in drug delivery and tissue engineering: from discovery to applications publication-title: Nano Lett. doi: 10.1021/nl102184c – volume: 132 start-page: 57 year: 2018 ident: 10.1016/j.jconrel.2018.12.019_bb0075 article-title: Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2018.06.012 – volume: 62 start-page: 3603 year: 2002 ident: 10.1016/j.jconrel.2018.12.019_bb0730 article-title: Bone Marrow-derived Mesenchymal Stem Cells as Vehicles for Interferon-β Delivery into Tumors publication-title: J. Control. Rel. – volume: 5 start-page: 9073 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0465 article-title: MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function publication-title: Sci. Rep. doi: 10.1038/srep09073 – volume: 111 start-page: 13481 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0785 article-title: Clearance of pathological antibodies using biomimetic nanoparticles publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1412420111 – volume: 5 start-page: 209 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0030 article-title: Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3006839 – volume: 196 start-page: 243 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0535 article-title: Nano-engineered mesenchymal stem cells as targeted therapeutic carriers publication-title: J Control. Rel. doi: 10.1016/j.jconrel.2014.10.015 – volume: 111 start-page: 17600 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0780 article-title: In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1418230111 – volume: 8 start-page: 61 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0425 article-title: Biomimetic functionalization with leukocyte membranes imparts cell like functions to synthetic particles publication-title: Nat. Nanotechnol. doi: 10.1038/nnano.2012.212 – volume: 22 start-page: 1128 year: 2004 ident: 10.1016/j.jconrel.2018.12.019_bb0350 article-title: CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells publication-title: Stem Cells doi: 10.1634/stemcells.2003-0196 – volume: 111 start-page: 846 year: 2010 ident: 10.1016/j.jconrel.2018.12.019_bb0280 article-title: Multilineage differentiation potential of cells isolated from the human amniotic membrane publication-title: J. Cell Biochem. doi: 10.1002/jcb.22769 – volume: 13 start-page: 5020 year: 2007 ident: 10.1016/j.jconrel.2018.12.019_bb0450 article-title: Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-07-0731 – volume: 9 start-page: 2698 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0645 article-title: Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection publication-title: Mol. Pharm. doi: 10.1021/mp300254s – volume: 65 start-page: 3307 year: 2005 ident: 10.1016/j.jconrel.2018.12.019_bb0235 article-title: Human bone marrow–derived mesenchymal stem cells in the treatment of gliomas publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-04-1874 – volume: 339 start-page: 971 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0065 article-title: Minimal self peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles publication-title: Science doi: 10.1126/science.1229568 – volume: 6 start-page: 2371 year: 2007 ident: 10.1016/j.jconrel.2018.12.019_bb0860 article-title: Therapeutic ultrasound facilitates antiangiogenic gene delivery and inhibits prostate tumor growth publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-07-0019 – volume: 108 start-page: 3938 year: 2006 ident: 10.1016/j.jconrel.2018.12.019_bb0490 article-title: Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells publication-title: Blood doi: 10.1182/blood-2006-05-025098 – volume: 2 start-page: 1 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0335 article-title: Molecular mechanisms of migration and homing of intravenously transplanted mesenchymal stem cells publication-title: J. Regener. Med. Tissue Eng. doi: 10.7243/2050-1218-2-4 – volume: 36 start-page: 90 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0580 article-title: Gadolinium-chelate nanoparticle entrapped human mesenchymal stem cell via photochemical internalization for cancer diagnosis publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.09.014 – volume: 5 start-page: 11374 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0805 article-title: Cell-derived vesicles as a bioplatform for the encapsulation of theranostic nanomaterials publication-title: Nanoscale doi: 10.1039/c3nr01541f – volume: 91 start-page: 140 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0210 article-title: A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer publication-title: Biomaterials doi: 10.1016/j.biomaterials.2016.03.023 – volume: 16 start-page: 5498 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0655 article-title: Adult stem cells seeded on electrospinning silk fibroin nanofiberous scaffold enhance wound repair and regeneration publication-title: J. Nanosci. Nanotechnol. doi: 10.1166/jnn.2016.11730 – volume: 75 start-page: 843 year: 2009 ident: 10.1016/j.jconrel.2018.12.019_bb0200 article-title: Radiation increases invasion of gene-modified mesenchymal stem cells into tumors publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2008.06.1953 – volume: 25 start-page: 2739 year: 2007 ident: 10.1016/j.jconrel.2018.12.019_bb0375 article-title: Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing publication-title: Stem Cells doi: 10.1634/stemcells.2007-0197 – volume: 54 start-page: 6326 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0410 article-title: In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: cell-based delivery system to target ocular surface diseases publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.13-12044 – start-page: 325 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0080 article-title: Applications of cell-based drug delivery systems: use of single cell assay – volume: 9 start-page: 2698 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0680 article-title: Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection publication-title: Mol. Pham. doi: 10.1021/mp300254s – volume: 26 start-page: 1590 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0215 article-title: Overexpression of hepatocyte nuclear factor-4alpha initiates cell cycle entry, but is not sufficient to promote beta-cell expansion in human islets publication-title: Mol. Endocrinol. doi: 10.1210/me.2012-1019 – volume: 21 start-page: 4880 year: 2010 ident: 10.1016/j.jconrel.2018.12.019_bb0555 article-title: Gold nanorods: from synthesis and properties to biological and biomedical applications publication-title: Adv. Mater. doi: 10.1002/adma.200802789 – volume: 407 start-page: 741 year: 2011 ident: 10.1016/j.jconrel.2018.12.019_bb0380 article-title: CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2011.03.093 – ident: 10.1016/j.jconrel.2018.12.019_bb0495 – volume: 30 start-page: 527 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0160 article-title: Therapeutic potential of bone marrow-derived mesenchymal stem cells producing pigment epithelium-derived factor in lung carcinoma publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2012.1015 – volume: 520 start-page: 1 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0635 article-title: Design of magnetic gene complexes as effective and serum resistant gene delivery systems for mesenchymal stem cells publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2017.01.041 – volume: 64 start-page: 1139 year: 2009 ident: 10.1016/j.jconrel.2018.12.019_bb0330 article-title: Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model publication-title: Neurosurgery doi: 10.1227/01.NEU.0000345646.85472.EA – volume: 108 start-page: 10980 year: 2011 ident: 10.1016/j.jconrel.2018.12.019_bb0765 article-title: Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform publication-title: Natl. cad. Sci. U. S. A. doi: 10.1073/pnas.1106634108 – volume: 209 start-page: 260 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0130 article-title: Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice publication-title: J Control. Rel. doi: 10.1016/j.jconrel.2015.05.007 – volume: 69 start-page: 638 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0260 article-title: Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma publication-title: Thorax doi: 10.1136/thoraxjnl-2013-204110 – ident: 10.1016/j.jconrel.2018.12.019_bb0810 doi: 10.1002/adfm.201801355 – volume: 148 start-page: 96 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0650 article-title: Design of cell niches for the regulation of stem cell fate in central nervous tissue regeneration publication-title: Mater. Lette. doi: 10.1016/j.matlet.2015.02.079 – volume: 251 start-page: 4930 year: 1976 ident: 10.1016/j.jconrel.2018.12.019_bb0740 article-title: Preparation and characterization of hormone-sensitive, resealed etythrocyte ghosts publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(17)33204-0 – volume: 28 start-page: 2109 year: 2010 ident: 10.1016/j.jconrel.2018.12.019_bb0145 article-title: Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells publication-title: Stem Cells doi: 10.1002/stem.533 – volume: 56 start-page: 1063 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0430 article-title: Human mesenchymal stem cells are recruited to injured liver in a β1-integrin and CD44 dependent manner publication-title: Hepatology doi: 10.1002/hep.25716 – volume: 66 start-page: 7216 year: 2006 ident: 10.1016/j.jconrel.2018.12.019_bb0295 article-title: Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-0040 – volume: 63 start-page: 960 year: 2011 ident: 10.1016/j.jconrel.2018.12.019_bb0340 article-title: Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice publication-title: Arthritis Rheum. doi: 10.1002/art.30203 – volume: 8 start-page: 9610 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0820 article-title: Macrophage cell membrane camouflaged Au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.6b00853 – volume: 28 start-page: 1005 year: 2010 ident: 10.1016/j.jconrel.2018.12.019_bb0090 article-title: European scientific, ethical, and legal issues on human stem cell research and regenerative medicine publication-title: Stem Cells doi: 10.1002/stem.436 – volume: 69 start-page: 638 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0685 article-title: Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma publication-title: Thorax doi: 10.1136/thoraxjnl-2013-204110 – volume: 130 start-page: 2455 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0245 article-title: Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase:uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma publication-title: Int. J. Cancer doi: 10.1002/ijc.26278 – volume: 24 start-page: 1254 year: 2006 ident: 10.1016/j.jconrel.2018.12.019_bb0395 article-title: Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases publication-title: Stem Cells doi: 10.1634/stemcells.2005-0271 – volume: 54 start-page: 1209 year: 2006 ident: 10.1016/j.jconrel.2018.12.019_bb0285 article-title: Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis publication-title: Arthritis Rheum. doi: 10.1002/art.21753 – volume: 16 start-page: 571 year: 2008 ident: 10.1016/j.jconrel.2018.12.019_bb0345 article-title: Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance publication-title: Mol. Ther. doi: 10.1038/sj.mt.6300374 – volume: 15 start-page: 730 year: 2008 ident: 10.1016/j.jconrel.2018.12.019_bb0440 article-title: Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells publication-title: Gene Ther. doi: 10.1038/gt.2008.39 – volume: 74 start-page: 277 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0045 article-title: A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer publication-title: Cancer Chemother. Pharmacol. doi: 10.1007/s00280-014-2498-5 – volume: 27 start-page: 753 year: 2009 ident: 10.1016/j.jconrel.2018.12.019_bb0085 article-title: Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds publication-title: Stem Cells doi: 10.1634/stemcells.2008-0831 – volume: 30 year: 2018 ident: 10.1016/j.jconrel.2018.12.019_bb0265 article-title: Cell membrane coating nanotechnology publication-title: Adv. Mater. doi: 10.1002/adma.201706759 – volume: 32 start-page: 2373 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0875 article-title: Ex vivo molecular rejuvenation improves the therapeutic activity of senescent human cardiac stem cells in a mouse model of myocardial infarction publication-title: Stem Cells doi: 10.1002/stem.1728 – volume: 96 start-page: 1593 year: 2004 ident: 10.1016/j.jconrel.2018.12.019_bb0180 article-title: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djh299 – volume: 35 start-page: 1446 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0365 article-title: Concise review: MSC adhesion cascade—insights into homing and transendothelial migration publication-title: Stem Cells doi: 10.1002/stem.2614 – volume: 22 start-page: 3114 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0470 article-title: Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo publication-title: Stem Cells Dev. doi: 10.1089/scd.2013.0249 – volume: 108 start-page: 863 year: 2003 ident: 10.1016/j.jconrel.2018.12.019_bb0315 article-title: Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution publication-title: Circulation doi: 10.1161/01.CIR.0000084828.50310.6A – volume: 26 start-page: 4627 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0550 article-title: Stem cells loaded with nanoparticles as a drug carrier for in vivo breast cancer therapy publication-title: Adv. Mater. doi: 10.1002/adma.201401550 – volume: 526 start-page: 118 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0745 article-title: Nanoparticle biointerfacing by platelet membrane cloaking publication-title: Nature doi: 10.1038/nature15373 – volume: 10 start-page: 257 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0135 article-title: Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection publication-title: Nanomedicine:Nanotechnology Biology and Medicine doi: 10.1016/j.nano.2013.06.003 – volume: 16 start-page: 1574 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0855 article-title: Nanoghosts as a novel natural nonviral gene delivery platform safely targeting multiple cancers publication-title: Nano Lett. doi: 10.1021/acs.nanolett.5b04237 – volume: 56 start-page: 600 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0695 article-title: Mesenchymal stem cell (MSC)-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene publication-title: J. Nucl. Med. doi: 10.2967/jnumed.114.146662 – volume: 8 start-page: 13724 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0770 article-title: Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome publication-title: Nat. Commun. doi: 10.1038/ncomms13724 – volume: 24 start-page: 462 year: 2006 ident: 10.1016/j.jconrel.2018.12.019_bb0070 article-title: Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells publication-title: Stem Cells doi: 10.1634/stemcells.2004-0331 – volume: 10 start-page: 299 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0140 article-title: Reversal of tumor growth by gene modification of mesenchymal stem cells using spermine-pullulan/DNA nanoparticles publication-title: J. Biomed. Nanotechnol. doi: 10.1166/jbn.2014.1712 – ident: 10.1016/j.jconrel.2018.12.019_bb0035 doi: 10.1073/pnas.1309566110 – volume: 25 start-page: 1434 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0355 article-title: CXCR5-overexpressing mesenchymal stromal cells exhibit enhanced homing and can decrease contact hypersensitivity publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.04.004 – volume: 7 start-page: 163 year: 2011 ident: 10.1016/j.jconrel.2018.12.019_bb0320 article-title: Both human and mouse mesenchymal stem cells promote breast cancer metastasis publication-title: Stem Cell Res. doi: 10.1016/j.scr.2011.05.002 – volume: 30 start-page: 831 year: 2002 ident: 10.1016/j.jconrel.2018.12.019_bb0445 article-title: Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture publication-title: Exp. Hematol. doi: 10.1016/S0301-472X(02)00829-9 – volume: 43 start-page: 2590 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0060 article-title: Mesoporous silica nanoparticles in biomedical applications publication-title: Chem. Soc. Rev. doi: 10.1039/c1cs15246g – volume: 9 start-page: 9678 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0560 article-title: Mesenchymal stem cells aggregate and deliver gold nanoparticles to tumors for photothermal therapy publication-title: ACS Nano doi: 10.1021/acsnano.5b02207 – volume: 14 start-page: 894 year: 2007 ident: 10.1016/j.jconrel.2018.12.019_bb0170 article-title: Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells publication-title: Cancer Gene Ther. doi: 10.1038/sj.cgt.7701079 – volume: 28 start-page: 382 year: 2000 ident: 10.1016/j.jconrel.2018.12.019_bb0600 article-title: Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells publication-title: Exp. Hemotol. doi: 10.1016/S0301-472X(00)00134-X – volume: 22 start-page: 1338 year: 2004 ident: 10.1016/j.jconrel.2018.12.019_bb0290 article-title: Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta publication-title: Stem cells doi: 10.1634/stemcells.2004-0058 – volume: 6 start-page: 1004 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0795 article-title: Safe and immunocompatible nanocarriers cloaked in RBC membranes for drug delivery to treat solid tumors publication-title: Theranostics doi: 10.7150/thno.14471 – volume: 352 start-page: 573 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0660 article-title: Transplantation of bone-marrow-derived mesenchymal and epidermal stem;cells contribute to wound healing with different regenerative features publication-title: Mol. Pharm. – volume: 160 start-page: 766 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0520 article-title: Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice publication-title: Br. J. Haematol. doi: 10.1111/bjh.12196 – volume: 22 start-page: 1338 year: 2004 ident: 10.1016/j.jconrel.2018.12.019_bb0510 article-title: Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta publication-title: Stem Cells doi: 10.1634/stemcells.2004-0058 – volume: 162 start-page: 464 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0105 article-title: Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases publication-title: J. Control. Rel. doi: 10.1016/j.jconrel.2012.07.034 – volume: 11 start-page: 768 year: 2005 ident: 10.1016/j.jconrel.2018.12.019_bb0865 article-title: Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.768.11.2 – volume: 2017 start-page: 1 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0705 article-title: Cells, human menstrual blood-derived mesenchymal stem cells as potential cell carriers for oncolytic adenovirus publication-title: Stem Cells Int. – volume: 315 start-page: 1650 year: 1986 ident: 10.1016/j.jconrel.2018.12.019_bb0305 article-title: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing publication-title: N. Engl. J. of medicine doi: 10.1056/NEJM198612253152606 – volume: 19 start-page: 345606 year: 2008 ident: 10.1016/j.jconrel.2018.12.019_bb0885 article-title: An efficient and user-friendly method for the synthesis of hexagonal-phase NaYF(4):Yb, Er/Tm nanocrystals with controllable shape and upconversion fluorescence publication-title: Nanotechnology doi: 10.1088/0957-4484/19/34/345606 – volume: 28 start-page: 9581 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0840 article-title: Cancer cell biomimetic nanoparticles for targeted therapy of homotypic tumors publication-title: Adv. Mater. doi: 10.1002/adma.201602173 – volume: 449 start-page: 557 year: 2007 ident: 10.1016/j.jconrel.2018.12.019_bb0900 article-title: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis publication-title: Nature doi: 10.1038/nature06188 – volume: 101 start-page: 2546 year: 2010 ident: 10.1016/j.jconrel.2018.12.019_bb0225 article-title: Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line publication-title: Cancer Sci. doi: 10.1111/j.1349-7006.2010.01738.x – volume: 254 start-page: 767 year: 2011 ident: 10.1016/j.jconrel.2018.12.019_bb0220 article-title: Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma publication-title: Ann. Surg. doi: 10.1097/SLA.0b013e3182368c4f – volume: 6 start-page: 466 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0385 article-title: NAP-2 secreted by human NK cells can stimulate mesenchymal stem/stromal cell recruitment publication-title: Stem Cells – volume: 24 start-page: 462 year: 2010 ident: 10.1016/j.jconrel.2018.12.019_bb0500 article-title: Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells publication-title: Stem Cells doi: 10.1634/stemcells.2004-0331 – volume: 488 start-page: 1 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0620 article-title: ScreenFect A: an efficient and low toxic liposome for gene delivery to mesenchymal stem cells publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2015.04.050 – volume: 250 start-page: 747 year: 2009 ident: 10.1016/j.jconrel.2018.12.019_bb0720 article-title: Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma publication-title: Ann. Surg. doi: 10.1097/SLA.0b013e3181bd62d0 – volume: 5 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0460 article-title: Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages publication-title: Oncoimmunology doi: 10.1080/2162402X.2016.1189052 – volume: 531 start-page: 90 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0115 article-title: Peptide modified mesenchymal stem cells as targeting delivery system transfected with miR-133b for the treatment of cerebral ischemia publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2017.08.073 – volume: 29 start-page: 1018 issue: 47 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0755 article-title: Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity publication-title: Adv. Mater. doi: 10.1002/adma.201703969 – volume: 24 start-page: 2808 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0255 article-title: IL-21 expressing mesenchymal stem cells prevent lethal B-Cell lymphoma through efficient delivery of IL-21, which redirects the immune system totarget the tumor publication-title: Stem Cells Dev. doi: 10.1089/scd.2015.0103 – volume: 4 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0420 article-title: Macrophage cell membrane camouflaged mesoporous silica nanocapsules for in vivo cancer therapy publication-title: Adv. Healthcare Mater. – volume: 103 start-page: 137 year: 2016 ident: 10.1016/j.jconrel.2018.12.019_bb0625 article-title: Integration of antimicrobial peptides with gold nanoparticles as unique non-viral vectors for gene delivery to mesenchymal stem cells with antibacterial activity publication-title: Biomaterials doi: 10.1016/j.biomaterials.2016.06.057 – volume: 44 start-page: 1072 year: 2008 ident: 10.1016/j.jconrel.2018.12.019_bb0435 article-title: Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells publication-title: J. Mol. Cell Cardiol. doi: 10.1016/j.yjmcc.2008.03.010 – volume: 12 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0700 article-title: Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer publication-title: Plos One doi: 10.1371/journal.pone.0190125 – volume: 6 year: 2011 ident: 10.1016/j.jconrel.2018.12.019_bb0370 article-title: Mesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shear publication-title: PLoS One doi: 10.1371/journal.pone.0025663 – volume: 22 start-page: 1141 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0585 article-title: Molecular imaging for in vivo tracking of stem cell fate publication-title: Macromol. Res. doi: 10.1007/s13233-014-2184-9 – volume: 25 start-page: 3881 year: 2015 ident: 10.1016/j.jconrel.2018.12.019_bb0760 article-title: Cell membrane coated synthetic nanomotors for effective biodetoxification publication-title: Adv. Fun. Mater. doi: 10.1002/adfm.201501050 – volume: 59 start-page: 942 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0870 article-title: Kusuoka, Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2011.11.029 – volume: 11 start-page: 3496 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0800 article-title: Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy publication-title: ACS Nano doi: 10.1021/acsnano.7b00133 – volume: 80 start-page: 12 year: 2014 ident: 10.1016/j.jconrel.2018.12.019_bb0360 article-title: Human umbilical cord blood-derived mesenchymal stromal cells display a novel interaction between P-selectin and galectin-1 publication-title: Scand. J. Immunol. doi: 10.1111/sji.12179 – volume: 45 year: 2013 ident: 10.1016/j.jconrel.2018.12.019_bb0270 article-title: Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine publication-title: Exp. Mol. Med. doi: 10.1038/emm.2013.94 – volume: 120 start-page: 1768 year: 2017 ident: 10.1016/j.jconrel.2018.12.019_bb0775 article-title: Fabrication of Synthetic Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.116.310374 – volume: 160 start-page: 117 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0040 article-title: Doxil(R)--the first FDA-approved nano-drug: lessons learned publication-title: J. Control. Release doi: 10.1016/j.jconrel.2012.03.020 – volume: 4 start-page: 128ra139 year: 2012 ident: 10.1016/j.jconrel.2018.12.019_bb0050 article-title: Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3003651 – volume: 62 start-page: 5351 year: 2002 ident: 10.1016/j.jconrel.2018.12.019_bb0895 article-title: The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types publication-title: Cancer Res. |
| SSID | ssj0005347 |
| Score | 2.642573 |
| SecondaryResourceType | review_article |
| Snippet | Owing to the diversity and ease of preparation of nanomaterials, the rational nanocarriers with a rational design have become increasingly popular in medical... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 102 |
| SubjectTerms | Animals Biomimetic Materials biomimetics Cell Membrane Cell membrane-coating cell membranes Cell-based target drug delivery system Drug Delivery Systems drugs gene transfer Gene Transfer Techniques genes Humans immune response immunogenicity Mesenchymal Stem Cells mesenchymal stromal cells mutation nanocarriers Nanoparticles Nanoparticles - administration & dosage neoplasms |
| Title | Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic |
| URI | https://dx.doi.org/10.1016/j.jconrel.2018.12.019 https://www.ncbi.nlm.nih.gov/pubmed/30553849 https://www.proquest.com/docview/2157657495 https://www.proquest.com/docview/2220853719 |
| Volume | 294 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT9wwFLYQXHqpCt0oi1wJccIzSbyGG0KgaVmEVJC4WfGSdkYwg2Y55MJv570sTJHaIvUUJbEt6_nF37Pzvs-E7Ok090VSeJYEqZgoXcKczgsG6OQCvCxFigTni0s1uBHfb-XtCjnuuDCYVtnO_c2cXs_W7ZN-a83-w3DY_wHBiuFK5uCUiQaUQwa70Ojlvcff0jy4aCjTyjAsvWTx9Ee9Eaw5pxH_QKSm3hVEwZ0_49Pf4s8ah07fkbdtAEmPmj6uk5U43iD7V40CdXVAr5eEqtkB3adXS23q6j05v0C2kf9V3UMbqOFMceeeIZYFGqaLnzTEO0zVqOis0a2tDilSUOpyMzqfUCTsD--R-_iB3JyeXB8PWHugAvMySecw33LtVJlzYVyUPstDaSCcczErtAwijc55nsSoZAxZKU0sEhg8uAqXBKU5_0hWx5Nx_ExocB7F2IPKUg-t5XkJsBdlAUAIMZx2m0R0ZrS-VRvHQy_ubJdWNrKt9S1a36aZBetvkt5ztYdGbuO1CqYbI_vCbyxAwmtVv3ZjauGbQjMW4zhZzCyEQVpJDWvHf5TJ8HRTrrGdT41DPPcYVdS4EfmX_-_cFnkDd5jKxjKzTVbn00XcgfBn7nZr_94la0ffzgaXTy7BBak |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELbocmgviD6hT1eqOGE2iZ_pDSHQUnZXSF0kblb8SLsr2EX7OOTfM7NJWCG1ReopUuyxrPFkZuzM95mQbzrNfZEUniVBKiZKlzCn84JBdHIBGkuRIsB5MFS9K_HjWl5vkZMWC4NllY3vr3362ls3b7qNNrt343H3JyQrhiuZg1EmGqLcM7KN7FSyQ7aPzy96w02lBxc1aloZhgIbIE93cjSBbec84k-I1KwPBpFz588h6m8p6DoUne2SnSaHpMf1NF-SrTh9RQ4uaxLq6pCONpiqxSE9oJcbeurqNekPEHDkf1e3MAbSOFM8vGcYzgIN89UvGuINVmtUdFFT11bfKaJQ1v0WdDmjiNkf3yL88Q25OjsdnfRYc6cC8zJJl-ByuXaqzLkwLkqf5aE0kNG5mBVaBpFG5zxPYlQyhqyUJhYJrB88hUuC0py_JZ3pbBr3CA3OIx97UFnqYbQ8LyHyRVlALIQ0Trt9Ilo1Wt8QjuO9Fze2rSyb2Eb7FrVv08yC9vfJ0YPYXc248ZSAadfIPjIdC1HhKdGv7Zpa-KxQjcU0zlYLC5mQVlLD9vEffTK84JRrHOddbRAPM0YiNW5E_v7_J_eFPO-NBn3bPx9efCAvoAUr21hmPpLOcr6KnyAbWrrPjbXfAxuECFo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mesenchymal+stem+cell-based+drug+delivery+strategy%3A+from+cells+to+biomimetic&rft.jtitle=Journal+of+controlled+release&rft.au=Wu%2C+Hong-Hui&rft.au=Zhou%2C+Yi&rft.au=Tabata%2C+Yasuhiko&rft.au=Gao%2C+Jian-Qing&rft.date=2019-01-28&rft.issn=0168-3659&rft.volume=294&rft.spage=102&rft.epage=113&rft_id=info:doi/10.1016%2Fj.jconrel.2018.12.019&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jconrel_2018_12_019 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-3659&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-3659&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-3659&client=summon |